Term
Impact from Infections on Human Health and Society |
|
Definition
- Economic and productivity influences
- Higher impact for children under <5 years old
- Children are more susceptible to diarrhea, malaria, and measles
- ~ 6 million children die worldwide each year
- Most disease are preventable
- Chronic infectious diseases --> Affect quality of life/disability and create a huge burden on the health care system
- 1 in 6 cancer cause be preventable and treatable infectious diseases --> HPV, Hep B, Hep C, and H. pylori |
|
|
Term
|
Definition
- Only have successfully eradicated small pox
- Polio is almost entirely eradicated but still around
- Eradication hindered by political, religious, economic, and trust issues around the world
- Problems in developed countries with the disputed connection between Autism and vaccines |
|
|
Term
Control and Prevention of Infection in Society |
|
Definition
- Requires four things
1. Effective epidemiological surveillance
2. Environmental sanitation and infection control
3. Implementation of immunization programs
4. Correct diagnosis and treatment of infections |
|
|
Term
Factors Increasing Morbidity and Mortality for Infections |
|
Definition
- Emerging and re-emerging infectious diseases --> 2/3 of diseases now are zoones
- Increased number of elderly and immunocompromised people
- Hospitals and invasive procedures & devices
- More food orignates outside the home
- Use of antimicrobial drugs
- Evolution of resistant, more virulent, and "vaccine-resistant" strains |
|
|
Term
|
Definition
- Make up the normal flora --> Microbiome
- Present in everyone all the time
- One benefits while the other neither benefits nor hurts
- Sources for opportunistic infections |
|
|
Term
|
Definition
- Usually present in the normal flora
- Become pathogens when host becomes immunocompromised or when the pathogen moves from his normal location |
|
|
Term
|
Definition
- Only associated with disease in the host
- Ex. Rabies, mycobacterium tuberculosis |
|
|
Term
Colonizing Microorganisms |
|
Definition
- Usually not pathogenic
- Organisms that are present in some but not in others
- Colonize area for a time and then go away
- Usually transient
- Ex. N. meningiditis --> Asymptomatic in the URT |
|
|
Term
Exogenous Sources of Microorganisms |
|
Definition
- Other people by direct transmission
- Vertical transmission (mother to fetus)
- Fomites: On inanimate objects
- Indirect transmission: Animals, insects, contaminated food, and water --> Many infections are caused by animal contact
- Healthcare-associated Infections: From procedural devices and machines |
|
|
Term
Endogenous Sources of Microorganisms |
|
Definition
- Normal flora/microbiome |
|
|
Term
|
Definition
- Germ Theory
1. Must be found in the body in all cases of diease
2. Must be isolated from the case and cultured
3. Must reproduce the disease from culture in another host
4. Must culture again from the other host |
|
|
Term
Systemic Clinical Signs of Infection |
|
Definition
- Flu-like symptoms
- Fever
- Chills
- Myalgias
- Loss of appetite
- Leukocytosis --> High WBC count and neutrophil count
- Due to innate immune response and TNF and IL-1
- Bands > Segs/polys |
|
|
Term
Localized Clinical Signs of Infection |
|
Definition
- Organism specific
- Usually confined to specific area of infection
- Erythema
- Inflammation
- Diarrhea
- Stomach pain |
|
|
Term
10 Things Hospitalists Should Know About Infections |
|
Definition
1. Availability of new drugs is shrinking due to resistance
2. Be familiar with new technology for identifying bugs
3. Beware of nuances treating S. aureus
4. Always remember C. difficile!!
5. Take out unncessary IVs
6. Be aware of urinary catheters and UTI risk
7. Urine culture without simultaneous urine analysis is worthless
8. Bactrim does NOT treat Strep
9. Take proper precautions with norovirus
10. Never swab decubitus ulcer unless clearly infected!! |
|
|
Term
Most Common Infections at BMC |
|
Definition
- E. Coli UTIs
- HIV
- Staph bacteremia
- Pneumonia
- Meningitis
- Cellulitis
- Diabetic foot infections
- Osteomyelitis
- Spontaneous peritonitis
- Infections in immunocompromised hosts --> Opportunistic
- Tuberculosis |
|
|
Term
|
Definition
- Microorganisms frequently found on or in the body of health persons --> Outnumber human cells 10-fold
- Cannot live without them!!
- Mostly anaerobic bacteria but also fungi, bacteriophage, and parasites
- Some are culturable while others are non-culturable
- Human Microbiome Project --> Determine health microbiome to see if it's different from those present in diseased patients
- No two microbiomes are alike --> Diversity is huge, even in just one person
- Still a few signature bacteria found in body sites |
|
|
Term
Microbiome Colonization of Newborns |
|
Definition
- Fetus grows in a sterile environment
- Becomes colonized during either vaginal or C-section deliveries
- Different subset of bacteria found depending on type of birth
- Also colonization depends on whether the mother breast feeds or not
- Gut bacteria colonization allows for increased carbohydrate break down of mother's milk
- Further colonized but interaction with family and environment |
|
|
Term
Factors that Alter Microbiome |
|
Definition
- Quite dynamic
- Change with age, change in diet, location, work environment, immune status, hormone levels and medications |
|
|
Term
|
Definition
- Clumps of bacteria within microbiome that become attached to the epithelial surface
- Usually attach the surface via pioneer bacteria
- Sometimes are present in biofilms
- Microcolonies then develop
- Other bacteria attach
- Palisading of bacteria --> Structure of a more "mature" microbiota/plaque |
|
|
Term
Primary Locations of Normal Flora |
|
Definition
- Large intestine --> Highest density!!
- Skin
- Upper respiratory tract
- Mouth
- Vagina
- Anterior part of the urethra |
|
|
Term
Protective Functions of the Normal Flora |
|
Definition
- Pathogen displacement --> Takes up space
- Nutrient competition
- Receptor competition
- Production of anti-microbial factors |
|
|
Term
Structural Functions of Normal Flora |
|
Definition
- Fortifies epithelial barriers
- Induces IgA production
- Induces apical tightening of tight junctions
- Helps develop immune system |
|
|
Term
Metabolic Functions of Normal Flora |
|
Definition
- Controls intestinal epithelial cell differentiation and proliferation
- Metabolizes dietary carbohydrates
- Synthesizes vitamins --> Vitamin K, biotin, and folate
- Ferments non-digestible dietary residues and endogenous epithelial-derived mucus
- Aids in ion absorption
- Helps to salvage energy |
|
|
Term
Normal Flora and Drug Metabolism |
|
Definition
- Gut bacteria can activate or inactivate drug
- Produce a toxic byproduct
- Produce an antimicrobial product
|
|
|
Term
Normal Flora and Allergic Diseases |
|
Definition
- Hygiene hypothesis
- Use of antibiotics clears out the normal gut flora
- Immune system ends up being under developed
- Alters antibody production to have IgE antibodies predominate
- IgE production induces eosinophil expansion
- Predisposes these people to allergic disease and asthma |
|
|
Term
Normal Flora and the Immune System |
|
Definition
- Normal flora actually stimulates immune system and helps develop it
- Keeps flora in check with IgA antibodies, mucous membranes, and microbials
- Underlying APCs and dendritic cells are constantly sampling the environment and responding to the bacteria encountered
- M-cells engulf pathogens and release them to the underlying APCs to initiate immune response
- Commensals fail to inhibit the NF-kB signaling pathway
- Pathogens do stimulate NF-kB signaling pathway |
|
|
Term
Normal Flora of Conjunctiva |
|
Definition
- Most important: Staph. aureus, coag-neg Staph., and Corynebacterium species
- Less important: Haemophilus spp and Streptococcus spp. |
|
|
Term
|
Definition
- Most Important Organisms: Staph. epidermidis
- Other: S. aureus, Corynebacterium, various Strep., Pseudomonas auruginosa, anaerobes, and yeast |
|
|
Term
|
Definition
- Most Important: S. aureus
- Other: S. epidermidis, Corynebacterium, and various Strep. |
|
|
Term
|
Definition
- Most important: Viridans streptococci
- Other: Streptococci and Elkenella corrodens |
|
|
Term
Normal Flora of Dental Plaque |
|
Definition
- Most Important: Streptococcus mutans
- Other: Prevotella intermedia and Porphyromonas gingivalis |
|
|
Term
Normal Flora of Gingival Crevices |
|
Definition
- Most imporant: Various anaerobes (Bacteroiodes, Fusobacterium, Streptococci, and Actinomyces) |
|
|
Term
|
Definition
- Most important: Viridans streptococci
- Other: Various streptococci, Neisseria spp., Haemophilus influenzae, S. epidermidis, and Moraxella |
|
|
Term
|
Definition
- Normally almost none
- Other: Helicobacter pylori, Lactobacillus spp. and Streptococcus spp. |
|
|
Term
|
Definition
- Most important: Bacteroiodes fragilis and E. coli
- Other: Bifidobacterium, Eubacterium, Fusobacterium, Lactoacillus, various Gram-negative rods, Enterocccus faecalis, Streptococci spp., and Clostridium spp. |
|
|
Term
|
Definition
- Most important: Lactobacillus spp., E. coli, and group B Streptococci
- Other: Various Streptococci, various Gram-negative rods, B. fragilis, Corynebacterium spp., and Candida spp. |
|
|
Term
|
Definition
- None are extremely important
- Others: S. epidermidis, coag-neg Staphylococcus spp., Corynebacterium, various Streptococci, various Gram-negative rods (E. coli) |
|
|
Term
|
Definition
- Deep tissues and organs
- CSF
- Blood
- Body fluids --> Urine |
|
|
Term
Diseases Associated with Alteration in Normal Flora |
|
Definition
- Dysbiosis
- Obesity and metabolic syndromes
- Inflammatory bowel disease
- Irritable bowel syndrome
- Asthma
- Antibiotic-associated diseases
- Autoimmune and inflammatory diseases
- Colon cancer
- Non-alcoholic fatty liver disease
- Atopy
- Hypertension |
|
|
Term
|
Definition
- Live microorganisms that confer a health benefit on the host
- Must be administered in adequate amounts |
|
|
Term
|
Definition
- Selectively fermented ingredients that stimulate specific changes in colinic microbiota
- Benefits the health of the host by stimulating microbiota growth |
|
|
Term
|
Definition
- Combination of pre and probiotics
- Designed to have a synergistic effect on benefit for the host |
|
|
Term
|
Definition
- Used in cases of severe microbiota dysbiosis
- Recurrent C. difficile infections even after cessation of antibiotics |
|
|
Term
|
Definition
- Process of determining the pathogen responsible for disease
1. All lab tests have potential for inaccuracy
2. Lab tests vary in sensitivity and what they measure
3. Identification of organism doesn't mean it is causing disease
4. Lab tests are just part of the picture!! |
|
|
Term
|
Definition
- Direct testing
1. Staining --> Gram or specific
2. Streak plate isolation --> Hope to get down to single colonies to observe appearance
3. Identification using tests and antibiotic susceptibility tests
- Some tests take longer than others
- Some look for toxins instead of bacteria
- Observe colonies: Apperances, hemolysis and odor
- Hospital specific antibiotic susceptibility tables are available!! |
|
|
Term
|
Definition
- Indirect detection
- Serology
- Detects antibody levels
- Acute serum: At or near onset of symptoms
- Convalescent serum: Taken at least 14 days after
- 4-fold increase in IgM antibodies --> Acute infection
- IgG antibodies --> Previous infection |
|
|
Term
When is Immunologic Detection Preferred? |
|
Definition
- Sampling or transport conditions are not favorable for organism
- Organism is non-culturable
- Molecular assay are unavailable
- In infections with bacterial shedding occurs before symptoms appear --> Bacteria would no longer be present in any samples taken |
|
|
Term
|
Definition
- Used with systemic infections/sepsis, endocarditis, meningitis, pneumonia, etc
- Gram-positive and Gram-negative bacteria can be responsible
- Need multiple specimens over 24 hours (2-3 tubes)
- Risk for contamination from skin (S. epidermidis)
- Special culture tubes are now available --> Don't need to open
- Be sure to collect before starting antibiotics!! |
|
|
Term
|
Definition
- Taken for pharyngitis/sore throat
- Want to swab the tonsils and the uvula
- Also swab pus containing sores if present
- Most commonly caused by viruses
- Bacterial causes: Strep. pyogenes (Group A)
- Cultured on blood agar usually
- Examine hemolysis |
|
|
Term
|
Definition
- Ordered when TB, lobar pneumonias, and atypical pneumonias are suspect
- Specimen from the lower respiratory tract
- Collected through coughing
- Must try not to contaminate with oralf flora
- Lab won't accept if too many squamous cells are present --> Contamination
- WBCs and mucous strings present on slide |
|
|
Term
|
Definition
- CSF is normally sterile
- Taken when meningitis is suspected
- Needle inserted between L3 + L4
- Cultures could come back negative --> Bacterial, fungal, and viral causes
- Common causes: N. meningiditis, S. pneumoniae, H. pneumoniae (elderly), and Cryptococcus neoformans (immunocompromised) |
|
|
Term
|
Definition
- Stained for WBCs to determine number
- Number differentiates between invasive and toxigenic organisms
- Variety of agars for culturing |
|
|
Term
|
Definition
- Urine should be sterile
- Easily contaminated by vaginal and skin flora simply due to normal flow
- Count CFUs present --> >100,000 CFUs/mL means UTI
- Try to obtain a mid-stream catch to decrease contamination |
|
|
Term
|
Definition
- Taken when STDs are suspected
- Pap smears for women or culturing a pus filled wound
- Organisms are very fastidious/fragile so must be handled with care |
|
|
Term
Wound and Abcess Cultures |
|
Definition
- Never culture decubitous wound unless clearly infected!!
- Clostridium in wounds covered with dirt
- S. aureus commonly in abcesses
- Animal and human bites show different bacterial infections |
|
|
Term
|
Definition
- Gram-positive cocci in clusters --> 40 different species
- Species: G. aureus, S. epidermidis, and other coag-neg. Staphylococcus
- Transient colonizers or part of normal flora
- Facultative anaerobes
- S. aureus: Yellow and B-hemolytic
- S. epidermidis: White, non-hemolytic |
|
|
Term
Staphylococcus Virulence Factors |
|
Definition
- Acquired by phage or another mobile genetic element
- Teichoic acid and lipoteichoic acid
- Some are encapsulated
- Protein A (S. aureus): Binds IgG antibodies
- Adhesion molecules --> Pili
- Production of toxins and enzymes |
|
|
Term
Determination of Staph vs. Strep |
|
Definition
- Look similar on gram staining --> G+ cocci
- Cause many of the same diseases --> impetigo, toxic shock syndrome, and endocarditis
- Catalase test
- Strep is neg. --> In chains
- Staph is pos. --> In clusters
- Both are facultative anaerobes though |
|
|
Term
Determination of Staphylococcus Species |
|
Definition
1. Coagulase test
- S. aureus --> Coag +
- S. epidermidis --> Coag -
- Lots of resistance in S. aureus but NOT in S. epidermidis
2. Growth on mannitol/salt agar
- Coag-neg. Staph: Growth but no color change
- S. aureus: Growth with color change |
|
|
Term
Transmission of Staphylococcus |
|
Definition
- Commonly found in the nostrils
- Skin-to-skin contact, fomites, and endogenous sources
- Liquid soaps can also be contaminated
- Commonly transmitted in hospitals, prisons, immunocompromised people, football players, and wrestling
- Respiratory and animal transmission also possible |
|
|
Term
Staphylococcus aureus Infections |
|
Definition
1.Skin infections most common: Abcess/boil containing leukocytes, necrotic tissue, and live/dead bacterial cells --> Surrounded by erythema and inflammation
2. Virulence factors: Protein A, capsule, adhesion molecules, toxins and enzymes
3. Toxins
4. Enzymes: Coagulase, hyaluronidase, staphylokinase, clumping factor, and lipase
5. Hemolysins and leukocidins produced
6. Diseases: Osteomyelitis, endocarditis, and pneumonia |
|
|
Term
Specific Staph. aureus Skin Infections |
|
Definition
- Folliculitis: Infection of the hair follicle
- Furuncles: Infection in fused hair follicles
- Carbuncles: Infection is large and extends deeper
- Stye: Infection of the eyelash
- Impetigo: Superficial infection usually on the face and limbs on children
- Bullous impetigo: Has blisters that never rupture
- Cellulitis: Deeper skin infection with no clear demarcation
- Abcess/empyema: Characteristic of S. aureus infection, need to be drained |
|
|
Term
|
Definition
- Can be caused by Staph or Strep
- Mediated by toxic shock protein --> Superantigen
- Toxin mediated
- Symptoms: Sunburn rash, desquamation, fever, hypotension |
|
|
Term
|
Definition
- Superficial skin disease caused primarily by S. aureus
- Caused by exfolliative toxin --> Superantigen |
|
|
Term
|
Definition
- Commonly caused by S. aureus
- Enterotoxin A-R
- Causes nausea, vomitting, and diarrhea
- Bacteria may already have shed by the time cultures are taken
- Must test for toxin instead |
|
|
Term
|
Definition
- Hot compresses
- Drain abcess
- Remove prothetics if necessary
- Antibiotics but must treat with the right one for particular strain |
|
|
Term
Methicillin-Resistant Staph. Aureus (MRSA) |
|
Definition
- Superbug --> USA300 strain is the most virulent, contagious, and survives the longest
- Not just hospital acquired anymore
- Antibiotic resistance: Plasmid transfer of pathogenicity island |
|
|
Term
Prevention of Staph. Infections |
|
Definition
- Good hygiene
- Prophylactic antibiotics only in special conditions
- No vaccine available |
|
|
Term
Staphylococcus epidermidis |
|
Definition
- Normal flora on skin
- White, non-hemolytic and coag. negative
- Novobicin-sensitive
- Treatment: Vancomycin
- Diseases: Osteomyelitis possible |
|
|
Term
Staphylococcus saprophyticus |
|
Definition
- White, non-hemolytic, and coag-neg.
- Novobicin-resistant
- Common cause of UTI
- Usually transmitted through sexual contact |
|
|
Term
Streptococcus Bacterial Species |
|
Definition
- Gram positive cocci in chains (usually short)
- Catalase neg.
- Groups A-R based on antigenic variation
- S. pyogenes (Group A), S. agalactiae (Group B), Enterococcus (Group D), S. pneumoniae, and Viridans streptococci
- Varying levels of hemolysis |
|
|
Term
|
Definition
- Group A strep: B-hemolytic
- Normal flora in throat
1. Virulence Factors: Capsule, pyrogenic exotoxins, and M protein
- Capsule: Made of hyaluronic acid
- M protein: Fimbrial antigen (>80 types) --> Mediates disease
2. Enzymes: Hyaluronidase, streptolysin A+O, streptokinase, NADase, streptodornases, and C5a peptidase
3. Toxins --> Pyrogenic/erythrogenic exotoxins and toxic shock syndrome
- Pyrogenic exotoxins --> Necrotizing fasciitis
4. Diseases: Meningitis, otitis, sinusitis, tonisilitis, pharyngitis, adenitis, pneumonia, endocarditis, skin, Scarlet Fever, and necrotizing fasciitis |
|
|
Term
|
Definition
- Usually caused by viruses
- Bacterial cause: S. pyogenes
- Can spread to otitis, meningitis, or Scarlet Fever |
|
|
Term
|
Definition
- Due to S. pyogenes in the throat
- Results when exotoxins are produced by bacteria
- Presents with high fever
- Rash starting on upper chest, spreading to the extremities but sparing the palms and soles of the feet
- Strawberry tongue possible |
|
|
Term
|
Definition
- Well demarcated
- Usually only on the face
- Caused by group A strep
- Impetigo also possible due to group A strep |
|
|
Term
|
Definition
- Caused by group A strep
- Highly destructive skin disease
- Site needs to be debreeded and possibly amputated
- Pathogenesis mediated by exotoxins and the resulting immune response |
|
|
Term
|
Definition
- Sequelae following skin infections
- Due to immune complexes building up in the kidney
- Type III hypersensitivity
- Immune complexes produced to the M protein of S. pyogenes
- Symptoms: Red face, hypertension, and smokey urine |
|
|
Term
|
Definition
- Caused by group A strep pharyngitis
- Autoimmune cardiac dysfunction occurs upon re-infection with group A strep
- Type II hypersensitivity
- Symptoms: Arthralgia, polyarthritis, and carditis |
|
|
Term
Laboratory Diagnosis of Group A vs. Group B Strep |
|
Definition
- Bacitracin resistance test
- Group B is resistant
- Group A is sensitive
- Also rapid tests available for group A strep |
|
|
Term
Treatment and Prevention of S. pyogenes |
|
Definition
- Treatment: Penicillin and prophylaxis for patients with or at risk for Rheumatic Fever
- Prevention: Good hygiene but NO vaccine |
|
|
Term
|
Definition
- Group B Strep
- B-hemolytic
- Passed from mother to baby --> Neonatal meningitis and possibly sepsis
- Virulence: Not well understood
- Bacitracin resistant
- CAMP test for Group B: + test enhances S. aureus hemolysis
- Treatment: Penicillin and prophylaxis in pregnant women |
|
|
Term
|
Definition
- G+ diplococci surrounded by capsule --> A-hemolytic
- Most common cause of community-acquired lobar pneumonia --> Present in all age groups except newborns
- Assymptomatic carriers possible
- Transmission: Respiratory droplets
- Virulence Factors: Capsule, IgA protease, pneumolysis, teichoic acid, peptidoglycan, and phosphocholine
- Diseases: Otitis, sinusitis, meningitis, and sepsis
- Optochin-sensitivite --> Testing method
- Treatment: Penicillin and 2nd generation cephalosporin
- Vaccines: PPSV23 and PCV-13 |
|
|
Term
|
Definition
- Usually doesn't cause disease in healthy people
- Can cause endocarditis and dental caries
- Ex. Strep. mutans --> Dental cavities
- G+ cocci --> A-hemolytic
- Optochin resistant |
|
|
Term
|
Definition
- Group D strep
- G+ cocci in chains
- Grow in presence of high salt and bile
- Enterocuccus faecalis --> Common catheter acquired UTI
- |
|
|
Term
|
Definition
- Many present as normal flora of the throat
- Gram-neg. diplococci --> "kissing coffee beans"
- Fastidious growth requirements and fragile
- Transmission: Close contact, usually through sexual contact
- Only grows on Thayer-Martin agar --> Heated blood agar and antimicrobials to help Neisseria spp.
- Virulence Factors: Pili, LOS, porin proteins, Opa proteins, and some have capsules
- N. meningiditis --> Can ferment glucose and maltose
- N. gonorrhoeae --> Can only ferment glucose |
|
|
Term
|
Definition
- Grows intracellularly in neutrophils
- Men are almost always symptomatic with purulent discharge
- 50-80% of women are assymptomatic --> Need PCR to diagnose
- Classified into strains based on pilin proteins
- 2nd most common bacterial STD --> Highest rates in 15-24 year olds
- Strict human pathogen
- Transmission: More likely transmitted from man to woman (~50%) |
|
|
Term
Pathogenesis of Gonorrhea |
|
Definition
- Aided by immune response
- Endocytosed by mucosal cells
- Transported to subendothelial space by mucosal cells
- Inflammation induced in subendothelial space by LOS and porins binding PRRs on APCs
- Late complement is crucial in immune response
- Virulence Factors: IgA protease, B-lactamase, pili, Opa protein, porins and LOS
- Antibodies are developed to virulence factors but antigenic variation is very common
- High re-infection rate |
|
|
Term
|
Definition
- Infection sites: Genital tract, rectum, conjunctiva, and oropharynx
- Incubation period: 2-14 days
- Symptoms: Present after 2-5 days
- Symptoms usually mild in women --> Painful urination and increased vaginal discharge
- Symptoms in men --> Purulent discharge, inflammation of urethra and painful urination
- Due to assymptomatic presentation --> Can lead to infertility and disseminated disease (sepsis)
|
|
|
Term
|
Definition
- Men: Gram staining of purulent exudate from urethral specimens
- Women: PCR necessary |
|
|
Term
Treatment and Prevention of Gonorrhea |
|
Definition
- Treatment: 3rd generation cephalosporin and azithromycin
- Penicillins and tetracylcines are NOT recommended
- Prevention: Safe sexual behaviors --> No vaccine |
|
|
Term
|
Definition
- Neisseria meningitidis
- Endemic disease in Africa --> Primarily in children
- ~ 1,000 cases/year in the US
- Common in dry, cold months
- Transmission: Respiratory droplets and close contact
- Humans are natural carriers in the nose --> 20-30% |
|
|
Term
Pathogenesis of N. meningitidis |
|
Definition
- Highly invasive --> Can go through cells and into blood
- Endotoxins can induce sepsis
- Encapsulated --> Increases virulence
- Symptoms: Fever, headache, stiff neck, light sensitivity and rash
- Purpura/meningiococcemia rash --> Can result due to blood infection |
|
|
Term
Immune Response to N. meningitidis |
|
Definition
- Antibodies produced --> Protective against re-infection
- Complement-mediated killing is crucial
- Inflammation: Sepsis can result from TNF-A and other inflammatory mediators |
|
|
Term
Treatment and Prevention of N. meningitidis |
|
Definition
- Treatment: Penicillin and 3rd generation cephalosporin
- Prophylaxis given to people in contact with a case --> Antibiotics and vaccine
- Vaccination: Based off of capsule --> Polyvalent vaccines |
|
|
Term
Pharmacokinetics vs. Pharmacodynamics of Antimicrobials |
|
Definition
- Pharmacokinetics: Absorption, distribution, and elimination
- Pharmacodynamics: Efficacy and toxicity of the drug
- Time-dependent: Efficacy depends on the time above MIC
- Concentration-dependent: Efficacy depends on peak concentration
- Bacteriocidal: More rapid killing and reduction of growth
- Bacteriostatic: Suppression of growth but no active killing --> Maybe due to relying on the immune system |
|
|
Term
Bacterial Cell Wall Synthesis Inhibitors |
|
Definition
- Penicillins
- Beta lactamase inhibitor combinations
- Cephalosporins
- Carbapenems
- Monobactams
- Vancomycin
- Mechanism of Action: Inhibits peptidoglycan synthesis by binding to penicillin binding protein and inhibits tetrapeptide linkage --> Cell lysis then occurs |
|
|
Term
Penicillin Spectrum Antibiotics |
|
Definition
- Rapidly bactericidal and time-dependent
1. Penicillin G (IV) and penicilin BK (PO) --> Narrow G+
2. Penicillinase resistant penicillins (nafcilin and dicloxacilin) --> G+ broad, especially Staph
3. Aminopenicillins (ampicillin) --> Narrow G+ and adds some G-
4. Carboxypenicillins and ureidopenicillins --> Narrower G+ and broad G-
- None do enterococci |
|
|
Term
Pharmacokinetics of Penicillins |
|
Definition
- Absorption: Good bioavailability, mostly IV/IM but some available PO (amoxicillin/penicillin)
- Distribution: Widely and 5-20% in CSF
- Metabolism: Minimal
- Excretion: Renal (unchanged) |
|
|
Term
Dosing Changes for Time vs. Concentration Dependent |
|
Definition
- Time-dependent --> Alter dose but keep interval the same
- Concentration dependent --> Alter interval but keep the dose the same --> Same peak
- Usually altered for renal disease but also for severe hepatic disease too |
|
|
Term
Adverse Effects of Penicillins |
|
Definition
- Hypersensitivity --> True anaphylaxis and cross reactivity with cephalosporins
- Thrombophlebitis
- GI distrubances
- Hematologic --> Leukopenia, etc
- Electrolyte disturbances --> Most common with carboxypenicillins (use ureidopenicillins instead
- Neurologic --> Reduce seizure threshold
- Interstitial nephritis |
|
|
Term
Acquisition of Antibiotic Resistance |
|
Definition
- Intrinsic: Within species (Klebsiella lactamase) --> Prevents drug from reaching site or inactivates drug
- Acquired: Resistance that develops --> Horizontally or vertically (hospitals)
- Mechanisms of resistance: Drug can't reach site, drug inactivated, target site altered, and efflux pumps |
|
|
Term
Penicillin and Cephalosporin Resistance |
|
Definition
1. Drug becomes inactivated by bacterial B-lactamases
- Produce penicillinases and cephalosporinases also
2. Bacteria can alter the structure of the penicillin binding proteins
3. Can alter the outer membrane permeability (G-) |
|
|
Term
Beta-Lactamase Inhibitors |
|
Definition
- Clavulanic acid
- Often used in combination with some penicillins
- Similar in structure to the bacterial beta-lactamases
- Inhibits some but not all beta-lactamases
- Prevents the destruction of antibiotic
- Enhances the spectrum and activity of the antibiotic |
|
|
Term
|
Definition
- Bacteriocidal and time-dependent
- None do Enterococci
1. 1st gen.: Cefazolin --> Broad G+ and narrow G-, mostly S. aureus!!
2. 2nd gen.: Cefuroxime --> Narrow G+ and broad G-
- Cephamycins: Cefoxitin --> Anaerobe activity, not really used clinically
3. 3rd gen.: Ceftriaxone --> Narrow G+ and Broad G- --> Good for penicillin resistant Strep.
4. 4th gen.: Cefepine --> Broad G+ and G- activity --> Good for Pseudomonas --> Don't always need that much activity |
|
|
Term
Pharmacokinetics of Cephalosporins |
|
Definition
- Absorption: Lower bioavailability for PO so IV for severe infections
- Only cefuroxime available PO
- Distribution: Widely distributed, including CSF
- Metabolism: Minimal
- Excretion: Mostly renal (unchanged)
- Longer half life than penicillins!! |
|
|
Term
Adverse Effects of Cephalosporins |
|
Definition
- Generally well tolerated
- Hypersensitivity possible --> Cross-reactivity with penicillin
- GI disturbances
- Hematologic
- Renal
- Nephrotoxicity |
|
|
Term
|
Definition
- Imipenem/cilastatin: Administered in combination because cilastatin prevents breakdown of impenem by renal dyhydropeptidases
- Bacteriocidal and time-dependent
- Broad spectrum: G+, G- and anaerobes
- Generally reserved for cases when strain is resistant to other penicillin drugs
- Resistant to hydrolysis but many B-lactamases |
|
|
Term
Pharmacokinetics of Carbapenems |
|
Definition
- Absorption: Only IV
- Distribution: Wide
- Metabolism: Minimal
- Excreted: Renal, highest concentrations in urine, and requires dose adjustment with renal dysfunction |
|
|
Term
Adverse Effects of Carbapenems |
|
Definition
- Hypersensitivity
- Seizures --> Lowers threshold
- GI distrubances |
|
|
Term
|
Definition
- Inhibits cell wall synthesis
- Bacteriocidal and time dependent --> Slower than penicillins and cephalosporins
- Activity: G+ aerobes including MRSA
- Uses: Strains resistant to penicillins, in patients unable to tolerate penicillins and 2nd line therapy for C. diff |
|
|
Term
Pharmacokinetics of Vancomycin |
|
Definition
- Absorption: Poor oral, only used PO for C. diff
- Distribution: Wide but not CNS
- Metabolism: Minimal
- Elimination: Renal excretion
- Monitor trough levels |
|
|
Term
Adverse Effects of Vancomycin |
|
Definition
- Infusion related effects --> Slow down infusion rate
- Hematologic
- Hypersensitivity
- Ototoxicity/Nephrotoxicity are rare |
|
|
Term
|
Definition
- Used clinically for over 30 years without resistance
- First vancomycin resistant enterococci (VRE) in Europe in the 80s
- Resistance due to increased clinical use and agricultural use
- Due to alterations in target site
- VISA/VRSA --> First appeared in 1996 |
|
|
Term
Protein Synthesis Inhibitors |
|
Definition
- Aminoglycosides
- Tetracyclines
- Macrolides
- Clindamycin |
|
|
Term
Nucleic Acids/Chromatin Structure Inhibitors |
|
Definition
- Quinolones
- Metronidazole |
|
|
Term
|
Definition
- Gentamicin
- Bacteriocidal and concentration dependent
- Mechanism: Passively diffuses through porins and oxygen dependent transport through membrane to bind 30S
- Reduced activity in anaerobic conditions and acidic environments
- Increased activity in combination with cell wall synthesis inhibitors
- Spectrum: G+ and G- aerobes, protozoa, and mycobacteria |
|
|
Term
Pharmacokinetics of Aminoglycosides |
|
Definition
- Absorption: Poor oral absoprtion
- Distribution: Only into extracellular space --> Hydrophillic
- Uses: In combination for most infections but alone for UTIs
- Metabolism: Minimal
- Elimination: Renal (unchanged) |
|
|
Term
Adverse Effects of Aminoglycosides |
|
Definition
- Nephrotoxicity: When concentrations are too high
- Ototoxicity
- Neuromuscular blockade
- Monitor peaks and troughs |
|
|
Term
Pharmacodynamics of Aminoglycosides |
|
Definition
- Post antibiotic effect: persistent suppression of bacterial growth following exposure to antibiotic
- Concentration dependent
- Cmax:MIC= 10:1
- Cmax: Peak drug concentration, must take into account protein binding |
|
|
Term
Penicillins and Aminoglycoside Treatment |
|
Definition
- Inhibit bacterial growth through synergy
- Penicllin: Inhibits cell wall synthesis
- Gentamicin: Inhibits protein synthesis
- Leads to increased bacterial killing
- Uses: Endocarditis and endovascular infections |
|
|
Term
Resistance to Aminoglycosides |
|
Definition
- Drug cannot reach target site
- Drug inactivated
- Target site is altered |
|
|
Term
|
Definition
- Tetracycline and doxycycline
- Bacteriostatic and time dependent --> Concentrates intracellularly
- Mechanism: Reversibly binds 30S ribosome
- Spectrum: G+, G-, anaerobes, Lyme, Brucellosis, Cholera, Syphilis, Chlamydia, and other atypicals
- Use: Mild/moderate respiratory infections and Lyme disease |
|
|
Term
Pharmacokinetics of Tetracyclines |
|
Definition
- Absorption: Good oral absorption but binds cations so absorption decreased by dairy and antacids
- Distribution: Wide but concentrates in bile, liver, kidney, spleen, skin, and bone
- Metabolism: Glucuronidation in liver
- Elimination: Excreted in urine and bile (Long half life) |
|
|
Term
Adverse Effects of Tetracyclines |
|
Definition
- Photosensitivity
- Tooth/bone discoloration (children)
- GI disturbances
- Hepatotoxicity
- Renal toxicity |
|
|
Term
Resistance to Tetracylcines |
|
Definition
- Drug can't reach target site --> Efflux pumps
- Drug is inactivated by enzymes
- Target site altered |
|
|
Term
|
Definition
- Azithromycin --> Bacteriostatic and time-dependent
- Concentrates intracellularly
- Mechanism: Reversibly binds 50S
- Spectrum: Broad G+, narrow G- and atypicals
- Azithromycin adds H. influenzae, Chlamydia, Mycoplasma, and Legionella activity
- Uses: Mild/moderate respiratory infections, alternative for patients with penicillin allergies and NOT used for blood, urine, or soft tissue infections |
|
|
Term
Pharmacokinetics of Azithromycin |
|
Definition
- Absorption: Good oral absorption but some food interactions
- Distribution: Distributes well, CSF too, but serum levels low because intracelllular concentrations of neutrophils and macrophages are high
- Metabolism: Liver and P450 inhibitor
- Elimination: Excretion in bile and urine --> Long half-life |
|
|
Term
Drug Interactions with Macrolides |
|
Definition
- CYP3A4 substrate and inhibitor
- Erythromycin is the worst
- Leads to increased levels of amiodarone, digoxin, warfarin, statins, Ca channel blockers, carbamezapine and others
- Mostly alters with cardio drugs |
|
|
Term
Adverse Effects of Macrolides |
|
Definition
- GI disturbances --> Nausea and vomiting
- QTc prolongation |
|
|
Term
|
Definition
- Drug cannot reach target --> Efflux pumps or decreased penetration into cell
- Drug inactivated by enzymes
- Target site altered |
|
|
Term
|
Definition
- Similar to macrolides
- Bacteriostatic and time dependent
- Mechanism: Reversibly binds 50S
- Spectrum: Broad coverage of G+ aerobes and G+ and G- anaerobes
- Uses: Pulmonary, pelvic/abdominal, and dental infections
- Alternative to patients allergic to penicillin |
|
|
Term
Pharmacokinetics of Clindamycin |
|
Definition
- Absorption: Good oral absorption, given IV or PO
- Distribution: Wide except CSF
- Metabolism: Oxidated in liver
- Elimination: Excreted in bile and urine |
|
|
Term
Adverse Effects of Clindamycin |
|
Definition
- GI disturbances --> Diarrhea and C. diff overgrowth
- Metallic taste |
|
|
Term
Resistance to Clindamycin |
|
Definition
- Cross resistance with macrolides
- Drug inactivated by enzymes
- Target site is altered |
|
|
Term
|
Definition
- Levofloxacin and ciprofloxacin --> Four generations
- Bacteriocidal and concentration dependent
- Mechanism: Inhibits topoisomerase II + IV --> Inhibits DNA replication
- Spectrum: Moderate G+, broad G- and atypicals
- Use: G- infections, respiratory, urine, soft tissue, and bone/joint infections, atypical infections (Shigella, Salmonella, and Mycobacteria), inhalation anthrax exposure, gastroenteritis, and prostatitis |
|
|
Term
Pharmacokinetics of Quinolones |
|
Definition
- Absorption: Excellent oral absorption, impaired by antacids and multivitamins
- Distribution: Wide
- Metabolism: Minimal
- Elimination: Renal (unchanged) |
|
|
Term
Adverse Effects of Quinolones |
|
Definition
- Generally well tolerated
- GI disturbances
- CNS --> Headache and dizziness
- Rash
- Photosensitivity
- QT prolongation
- Hypo/hyperglycemia
- Tendon rupture |
|
|
Term
|
Definition
- Drug cannot reach target --> Efflux pumps
- Drug inactivated
- Target site is altered --> one step point mutation
- Increasing prevalence of resistance --> Widely used |
|
|
Term
|
Definition
- Bactericidal and concentration dependent
- Mechanism: Enters cell and reduced to cytotoxic product and damages DNA, RNA and proteins
- Spectrum: G+ and G- anaerobes and protozoa
- Use: C. difficile colitis (1st line), and other anaerobic infections below the diaphram |
|
|
Term
Pharmacokinetics of Metronidazole |
|
Definition
- Absorption: Excellent oral absorption
- Distribution: Wide and CSF
- Metabolism: Active metabolites from liver
- Elimination: Urine and feces --> Adjust for liver and renal dysfunction |
|
|
Term
Adverse Effects of Metronidazole |
|
Definition
- Generally well tolerated
- GI disturbances
- Metallic taste
- Disulfiram reaction with alcohol!!!
- Peripheral neuropathy |
|
|
Term
Sulfamides and Trimethoprim |
|
Definition
- Trimethoprim/sulfamethoxazole (Bactrim): Antifolate sulfa drugs
- Bacteriostatic
- Sulfonamids: Inhibits Dihydropteroate synthase by competing with PABA
- Trimethoprim: Inhibits dihydrofolate reductase
- Mechanism: Inhibits DNA synthesis
- Spectrum: G+ aerobes including MRSA, G- aerobes, Listeria, Shigella, and Pneumocystis jiroveci
- Uses: UTIs, PCP pneumonia, Stenotrophomonas, skin/soft tissue infections caused by S. aureus, and reported failure in abcesses and bacteremia |
|
|
Term
Pharmacokinetics of Sulfonamides and Trimethoprim |
|
Definition
- Absorption: Good oral absorption --> PO or IV
- Distribution: Wide, moderate CSF and concentrates in urine
- Metabolism: Minimal
- Elimination: Renal excretion --> Competes with creatinine for excretion
- Patients may seem to show renal failure, but not truly renal failure |
|
|
Term
Adverse Effects of Sulfonamides and Trimethoprim |
|
Definition
- Hypersensitivity: Common and can cause serious rashes
- Hematologic: Decreased WBCs, RBCs, and platelets
- Photosensitivity
- Crystalluria with acid pH --> Can cause renal failure |
|
|
Term
Resistance to Sulfonamides and Trimethoprim |
|
Definition
- Sulfonamides: Decreased cell permeability, overproduction of PABA, and production of mutant folate enzyme
- Trimethoprim: Decreased cell permeability, overproduction of dihydrofolate reductase, and production of mutant reductase enzyme |
|
|
Term
|
Definition
- Isoniazid
- Rifampin
- Commonly used in combination with other agents
- Resistance develops quickly |
|
|
Term
|
Definition
- Multi-Drug Resistant (MDR): Resistant to at least isoniazid and rifampin
- Extensively Drug Resistant (XDR): Resistance to at least isoniazid, rifampin, any fluoroquinolone and one second-line injectable drug |
|
|
Term
|
Definition
- Bacteriocidal
- Mechanism: Inhibits mycolic acid synthesis
- Spectrum: Only Mycobacteria |
|
|
Term
Pharmacokinetics of Isoniazid |
|
Definition
- Absorption: Good oral absorption
- Distribution: Widely distributed and CSF
- Metabolism: Acetylation by liver
- Elimination: Renal excretion |
|
|
Term
Adverse Effects of Isoniazid |
|
Definition
- Hepatotoxicity: 10-20% asymptomatic, most commonly 1-2 months after treatment
- Peripheral neuropathy: <20%, supplement with vitamin B6
- Skin reactions: Urticaria |
|
|
Term
|
Definition
- Bacteriocidal
- Mechanism: Blocks bacterial RNA polymerase
- Spectrum: Mycobacteria and G+/G- organisms
- Use: Mycobacterial infections and G+ bacterial infections
- Given in combination with other therapies |
|
|
Term
Pharmacokinetics of Rifampin |
|
Definition
- Absorption: Good oral absorption
- Distribution: Lipophilic and variable CSF penetration
- Metabolism: Deacetylated to active form and induces P450 enzymes
- Elimination: Excreted through bile and enterohepatic recirculation |
|
|
Term
Drug Interactions with Rifampin |
|
Definition
- CYP450 inducer
- Reduces levels of clarithromycin, fluconazole, protease inhibitors, other HIV drugs, cardiovascular agents, and others |
|
|
Term
Adverse Effects of Rifampin |
|
Definition
- Rash
- GI distrubances
- Hepatotoxicity
- Orange body fluids
- Flu-like syndrome |
|
|
Term
|
Definition
- Amphotericin B --> Fungicidal
- Mechanism: Binds egosterol, leading to increased membrane permeability
- Spectrum: Yeasts (Candida, Cryptococcus, histoplasmosis, and blastomycoses) and molds (Aspergillus and mucormycosis)
- Use: Gold standard of antifungals |
|
|
Term
Pharmacokinetics of Amphotericin B |
|
Definition
- Absorption: IV only
- Distributed: Accumulates in tissues, very lipophilic
- Metabolism: None
- Elimination: Excreted in bile and urine minimally --> Long half-life
- 3 lipids have been added to formulation so dosing is different for all!! |
|
|
Term
Adverse Effects of Amphotericin B |
|
Definition
- Toxicity usually limits use --> Lipid products help decrease nephrotoxicity through macrophage endocytosis
- Nephrotoxicity: Glomerular or tubular due to cytokine release
- Infusion fever reactions: Chills, fever and tachypnea
- Electrolyte disturbances: K and Mg wasting
- Hematologic disturbances
- Hepatotoxicity |
|
|
Term
|
Definition
- Fungistatic
- Fluconazole, itraconazole, and voriconazole
- Mechanism: Inhibits fungal P450 enzymes
- Metabolism: Metabolized in the liver to different extents
- Adverse effects: Hepatotoxicity |
|
|
Term
|
Definition
- Azole
- Spectrum: Candida and Cryptococcus species
- Use: Mucocutaneous candidiasis, suspceptible invasive candidiasis, and 2nd line for Cryptococcal meningitis
- Resistance: Common in C. glabrata --> Dose dependent susceptibility |
|
|
Term
Pharmacokinetics of Fluconazole |
|
Definition
- Absorption: IV and PO
- Distribution: Wide including CSF
- Metabolism: CYP450 inhibitor --> Less than other azoles
- Elimination: Urine and bile |
|
|
Term
Adverse Effects of Fluconazole |
|
Definition
- Generally well tolerated
- GI effects
- Elevations of LFTs
- Reversible alopecia
- QT prolongation |
|
|
Term
|
Definition
- Caspofungin
- Fungicidal
- Mechanism: Inhibits fungal cell wall synthesis by inhibiting glucan synthase
- Spectrum: Broad Candida coverage and Aspergillus
- Use: Invasive candidiasis, and 2nd line for invasive Aspergillus |
|
|
Term
Pharmacokinetics of Echinocandins |
|
Definition
- Absorption: IV only
- Distribution: Widely distributed
- Metabolism: Hydrolysis and N-acetylation in the liver
- Elimination: Excreted in bile, feces, and urine |
|
|
Term
Adverse Effects for Echinocandins |
|
Definition
- Generally well tolerated
- Hepatotoxicity (rare)
- Nephrotoxicity (rare)
- Hypersensitivity (rare)
- Increased liver enzymes
- Expensive treatment for Candida |
|
|
Term
|
Definition
- Mechanism: De-aminated to 5-FU (chemo) within the cell and inhibits DNA and RNA synthesis
- Spectrum: Candida and Cryptococcus species
- Use: Combination therapy with amphotericin B
- Adverse Effects: Rash, hepatotoxicity, and myelosuppression (5-FU)
- Resistance: Used in combination to avoid resistance |
|
|
Term
Pharmacokinetics of Flucytosine |
|
Definition
- Absorption: Rapid oral absorption
- Distributed: Widely distributed including CSF
- Metabolism: Minimal
- Elimination: 90% excreted unchanged in urine
- Must monitor levels in patients with renal dysfunction
- Must watch 5-FU levels for toxicity!! |
|
|
Term
Corynebacterium diptheriae |
|
Definition
- Gram-positive, club shaped with red metachromatic granules
- Aerobic, non-motile and catalase-positive
- Toxigenic and non-toxigenic strains possible --> Classic A-B exotoxin --> Expressed with low Fe levels
- Humans are only reservoir --> Asymptomatic carrier in URT, GI, UGT, and skin
- Most people in the US are vaccinated --> Don't always get boosters so elderly at risk
- Transmission: Respiratory droplet and skin contact |
|
|
Term
Pathogenesis of Respiratory C. diptheriae |
|
Definition
- Local attachment to epithelial cells in the pharynx
- Replication and release of toxins in the pharyns
- Incubation: 2-4 days
- Symptoms: Pharyngitis with exudate and low-grade fever
- Pseudomembrane including necrotic tissue develops
- Severe cases: Neck swelling and systemic complications
- Children: Pseudomembrane can grow or become dislodged to block trachea |
|
|
Term
Pathogenesis of Cutaneous C. diptheriae |
|
Definition
- Entry through skin breaks
- Papule develops into non-healing ulcer
- Grayish pseudomembrane may also result |
|
|
Term
Diagnosis of C. diptheriae |
|
Definition
- Clinical presentation
- Gram stain (G+) and granule staining
- Culture on Loeffler's medium and Tellurite agar
- Testing for toxin: Elek test and PCR performed |
|
|
Term
Treatment and Prevention of C. diptheriae |
|
Definition
- Treatment: Administration of antitoxin and penicillin/erythromycin treatment
- Prevention: DTaP and Tdap vaccines and Td boosters every 10 years |
|
|
Term
|
Definition
- Non-diphtherial corynebacteria
- Can also cause disease!! |
|
|
Term
|
Definition
- G- rod in pairs
- Usually motile, obligate aerobe
- Oxidase + and non-lactose fermenter
- Virulence: Capsule in some species and antibiotic resistance
- Ubiquitous in the environment --> Grows in water
- Opportunistic pathogen --> Not common flora
- Risk groups: Burn and cystic fibrosis patients, urinary cathers, immunosuppression, or broad-spectrum antibiotics
- Responsible for ~10% of hospital infections |
|
|
Term
Virulence Factors and Presentation of Pseudomonas aeruginosa |
|
Definition
- Capsule, pili, and flagella
- Exotoxins: Toxin A, hemolysis, phospholipase C, pyocyanin (pigment), proteases, exoenzyme S, and leukocidin
- Infection sites: Ear, eye, skin, respiratory tract, UTI and CNS infections, endocarditis and bacteremia |
|
|
Term
Diagnosis of P. aeruginosa |
|
Definition
- Lac - on MacConkey Agar
- Produces pyocyanin --> Green colored on agar
- Smells like grape kool-aid
- Also need susceptibility testing too!! |
|
|
Term
Treatment and Prevention of P. aeruginosa |
|
Definition
- Treatment: Antibiotics and combination therapy
- Prevention: Infection control
- Prophylactic use is NOT recommended |
|
|
Term
|
Definition
- G+ coccobacilli in pairs or short chains
- Mobile --> Characteristic tumbling
- Facultative anaerobe and intracellular pathogen
- Grows in broad temperature ranges!!
- Ubiquitous in environment --> ~1,600 cases/year
- Transient colonizer of humans
- Transmission: Contaminated food and from mother to fetus
- Serious disease: Neonates, elderly, pregnant women, and complement deficiency |
|
|
Term
Pathogenesis of L. monocytogenes |
|
Definition
- Attachment to receptors on GI epithelium (enterocytes and M cells) --> Travels into Peyer's patches
- Phagocytosed but escapes phagolysosome by secreting Listeriolysin O
- Replicates within the cytoplasm
- Forms actin tail to travel to neighboring cells --> Dissemination |
|
|
Term
Clinical Presentation of L. monocytogenes |
|
Definition
- Health adults: asymptomatic flu-like illness with or without GI symptoms
- Pregnant women: Flu-like illness but meningitis possible
- Fetus and newborn are at high risk --> Meningitis
- Immunocompromised and elderly: Higher risk of meningitis |
|
|
Term
Diagnosis, Treatment and Prevention of L. monocytogenes |
|
Definition
- Diagnosis: Isolation of organism in CSF --> Specific tests
- Treatment: Ampicillin/penicillin with gentamicin in CNS infections
- Prevention: Safe food handling and consumption
- No vaccine available |
|
|
Term
|
Definition
- Non-lobar pneumonia --> Diffuse patchiness
- Chlamydia, leigonella and mycoplasma |
|
|
Term
|
Definition
- Below glottis
- Bronchitis, pneumonia and bronchiolitis |
|
|
Term
|
Definition
- Above the glottis
- Pharyngitis, laryngitis, otitis, tonsillitis, rhinitis, and sinusitis |
|
|
Term
|
Definition
- Infection or inflammation of the lung most often caused by infectious organisms
- Community acquired vs. hospital acquired
- Typical vs. atypical
- Other: Aspiration, post-viral, and special at-risk populations |
|
|
Term
Community Acquired Pneumonia |
|
Definition
- Streptococcus pneumonia
- Viruses: Influenza virus, adenovirus, parainfluenza virus
- Atypical: C. pneumoniae, L. pneumophilia, and M. pneumoniae
- Haemophilus influenzae |
|
|
Term
|
Definition
1. Chlamydiae --> Chlamydia trachomatis
2. Chlamydophila --> C. pneumoniae and C. psittaci
- G-, obligate intracellular parasite, and no peptidoglycan cell wall |
|
|
Term
Replication of Chlamydiae |
|
Definition
- Non-culturable --> Replications intracellularly
- Elementary body: Taken up by endocytosis
- Becomes active reticulate body within cell
- Reticulate bodies replicate
- Reticulate bodies return to elementary body state
- Elementary bodies released from cells |
|
|
Term
|
Definition
- Human pathogen only
- Transmission: Close contact, usually sexual
- >19 serovars --> Different diseases
- Syndromes: Trachoma, STI, adult conjunctivitis, and perinatal acquired conjunctivitis and pneumonia |
|
|
Term
Eye Infections Caused by Chlamydia |
|
Definition
- Conjunctivitis: Inflammation of the conjunctiva (membrane lining of eyelid)
- Keratitis: Inflammation of the cornea
- Trachoma |
|
|
Term
|
Definition
- Active trachoma: Occular infection, conjunctival inflammation and follicle formation
- Cicatricial disease: Eyelid scarring, trichiasis (ingrown eyelashes), and corneal opacification and blindness
- Common cause of blindness in developing countries
- >80 million with trachoma, >7 million have trichiasis, and >1 million have blindness |
|
|
Term
Sexually Transmitted Illnesses Caused by Chlamydia |
|
Definition
- Women: vaginitis, endometriosis, salpingitis, and oophoritis --> Can lead to PID and infertility
- Men: Lymphogranuloma venereum (LGV) in men who have sex with men, proctitis, and urethritis
- Men and women are often asymptomatic
- Infects epithelial cells, replicates and induces inflammation |
|
|
Term
Diagnosis, Treatment and Prevention of Chlamydia |
|
Definition
- Diagnosis: NAATs necessary
- Treatment: Azithromycin, treat sexual contacts, test for other STIs and treat neonates born to infected mothers
- Prevention: Barrier protection during sex |
|
|
Term
|
Definition
- Multifocal, patchy consolidation throughout lungs
- Cause of atypical pneumonia
- Transmission: Person-to-person via respiratory droplets
- Treatment: Azithromycin |
|
|
Term
|
Definition
- Causes atypical pneumonia
- Transmission: From exotic birds such as macaws, also from poultry
- Treatment: Azithromycin |
|
|
Term
|
Definition
- G- rod
- Facultative intracellular parasite
- Grows in freshwater amoeaba in nature, macrophages, monocytes, and epithelial cells
- Forms biofilms in human-made water systems
- Multiple serogroups
- Diagnosis: Special culture conditions with Fe, cystine, and charcoal
- Transmission: Inhalation of contaminated water --> No human-to-human transmission |
|
|
Term
Replication of Legionella pneumophila |
|
Definition
1. Entry via endocytosis --> Various mechanisms including secretion systems
2. Phagosome does not fuse with lysosome --> Evades killing
3. Organisms replicates in vacuole and produces cytotoxic enzymes |
|
|
Term
|
Definition
- Replicates in macrophages --> Stimulates inflammatory response
- Organism produces various enzymes and exotoxins
- LPS --> Endotoxin!!
- Cell mediated response contributes to pathogenesis
- Most commonly affects adults
- Legionnaire's Disease: More severe disease, presents as pneumonia --> Decreased rate but increased mortality
- Pontiac Fever: Less severe disease (mild flu) --> Increased rate but decreased mortality
- Caused by the same pathogen --> Unclear why this is possible |
|
|
Term
|
Definition
- No cell wall --> Gram stains don't work
- Membrane containing sterols --> Special media with sterols and lipids to grow
- Strict aerobe --> Replications extracellularly
- Strict human pathogen --> ~ 2 million/year (5-15 y.o.)
- Common colonizer in the URT and LRT --> Asymptomatic carrier
- Transmission: Respiratory droplets --> VERY contagious
- Treatment: Cell wall targeting antibiotics don't work!!
- Presentation: Atypical pneumonia |
|
|
Term
Pathogenesis of M. pneumoniae |
|
Definition
- Incubation: 2-3 weeks --> tracheobronchitis, low-grade fever, malaise, and headache
1. Adhesion binds ciliated epithelium in lungs
2. Bacteria produces H2O2 and cold agglutinins --> Cells die
- Kills off the mucociliary escalator --> Persistent cough
- Atypical pneumonia: "walking pneumonia" --> Patchy bronchopneumonia |
|
|
Term
Diagnosis, Treatment and Prevention of M. pneumoniae |
|
Definition
- Diagnosis: Serology and PCR
- Treatment: Erythromycin
- Prevention: Not much... No vaccine |
|
|
Term
|
Definition
- Commonly caused by Herpes, Syphilis, and Chancroid
- Syphilis: Single lesion, clean base, without pain and non-tender bilateral lymphadenopathy
- Chancroid: Multiple lesions, dirty base with pain and tender unilateral lymphadenopathy
- Herpes: Multiple lesions, clean base with pain and tender bilateral lymphadenopathy |
|
|
Term
|
Definition
- Spirochete --> Detected via darkfield mycroscopy and serology
- Treatment: Penicillin G
- More common in younger men --> Homosexual men
- Equally symptomatic in men and women |
|
|
Term
|
Definition
- Presents as a chancre --> Resolves even without treatment
- Can disseminate to secondary
- Treatment: Penicillin |
|
|
Term
|
Definition
- Systemic disease --> Maculopapillary rash and lymphadenopathy
- Rash includes the palms and soles of the feet
- Does not develop in everyone
- Condylomata lata: Lesions on the genitalia
- Will recover without treatment but lesions contain organisms |
|
|
Term
|
Definition
- Early latent --> 1 year after symptoms --> Can have sudden outbreaks of rash and highly contagious!!
- Late latent --> Not really contagious and no presence of organisms |
|
|
Term
|
Definition
- Can present months or decades after secondary
- Due to disseminated disease
- Late benign disease --> Granulomas/gummas in cartilage, bone, liver, heart and brain
- Neurosyphilis |
|
|
Term
|
Definition
- Argyll-Robertson pupil is common: Pupils constrict with accommodation but not to light and pupils are small and irregular
- Loss of coordination
- Abnormal gait |
|
|
Term
|
Definition
- Passed from mother to fetus
- Shows up weeks to months after birth
- Symptoms: Sniffles/nasal discharge contaning organisms and rash
- Rash can be either pustular or bullous
- Bone, eye, ear, and tooth malformations
- Eye: Anterior uveitis and interstitial kratitis |
|
|
Term
|
Definition
- History and physical exam
- Non-specific serology test followed by specific serology test
- Non-specific (VDRL and RPR)
- Specific (FTA-ABS, TPHA, and MHA-TP) |
|
|
Term
|
Definition
- Penicillin
- Patient with penicillin allergy --> Can use erythromycin, doxycycline or tetracycline instead but ALOT less effective
- Patient's with neurosyphilis, congenital syphilis and pregnant women should be desensitized and given penicillin
- Follow-Up Testing: Should see a drop in titer --> 4-fold decrease in non-specific antibodies if treatment worked |
|
|
Term
Jarish-Herxheimer Reaction |
|
Definition
- Occurs in 1/3-2/3 of patients
- Acute febrile reaction --> Fevers, chills, arthralgias, headache and more prominent lesions
- Due to release of treponemal consituents
- Must warn patients about this!! |
|
|
Term
Nonveneral Treponematoses |
|
Definition
- Not seen in the US
- Bejel
- Yaws
- Pinta
- May cross-react and give a false positive for syphilis |
|
|
Term
|
Definition
- Pathogen causing chancroid
- Incubation: 3-10 days --> Soft painful chancre
- Multiple lesions are common
- Painful inguinal lymphadenitis |
|
|
Term
Diagnosis and Treatment of Haemophilius ducreyi |
|
Definition
- History and physical exam
- Gram stain of exudate --> Suggestive of infection
- Culture not generally available
- Other tests not really available either
- Treatment: Azithromycin, ceftriaxone, and ciprofloxacin |
|
|
Term
|
Definition
- Transmitted from animals to humans
- Directly transmitted
- Vector transmitted --> Insects, mice, fleas, etc
- Most common: Lyme disease
- Most life-threatening: Rocky Mountain Spotted Fever |
|
|
Term
|
Definition
- G- cocci but do not stain well
- Obligate intracellular parasites
- Symptoms: Fever, headache, rash and multi-system involvement
- Symptoms due to replication and death of vascular endothelial cells
- Ex. Rocky Mountain Spotted Fever and Typhus
- Rash: Usually several days after fever and photosensitivity, includes palms and soles of the feet
- Common in chlidren --> Often not diagnosed because it's rare |
|
|
Term
|
Definition
- Cause of Rocky Mountain Spotted Fever (RMSF)
- Vector: Dog tick
- Reservoir: Dogs, rodents, and ticks
- Location: SE states and central US
- Events: R. rickettsii transmitted to human through bite, bacteria replicate in endothelial cells, rash may appear 2-6 days after and may result in multi-organ disease
- Symptoms: Severe headache, high fever, and rash
- Rash: Begins on hands and feet and spreads inward
- Treatment: Doxycycline --> Fatal without treatment!! |
|
|
Term
|
Definition
- Cause of epidemic typhus --> Common in developing countries with low hygiene
- Human lice (Vector, reservoir and host)
- Symptoms: incubation 1-3 weeks, flu-like symptoms, fever, headache, chills, and rash
- Rash: Begins on trunk and extends peripherally but spares palms and soles
- Often presents with escar
- Can cause coma and vascular collapse without treatment but not as fatal as RMSF
- Treatment: Doxycycline |
|
|
Term
|
Definition
- Causes endemic/murine typhus --> 20-80 cases/year in US
- Vector: Fleas
- Reservoir: Rats
- Symptoms: Fever, headache, and rash
- Rash: Restricted to chest
- Often presents with escar |
|
|
Term
Diagnosis of Rickettsial Diseases |
|
Definition
- Growth is difficult but possible
- Serological tests can be done but not generally
- Typical presumptive diagnosis based on presentation and history |
|
|
Term
Treatment and Prevention of Rickettsial Disease |
|
Definition
- Treatment: Doxycycline
- Prevention: Dress appropriately when outside, avoid exposure, do tick inspections
- Tick must be attached for 24-48 hours in order to transmit disease!! |
|
|
Term
|
Definition
- G- coccobacillus bacteria causing Q fever --> ~130 cases/year in the US
- Obligate intracellular pathogens --> Difficult to stain
- Risk factors: Working with animals
- Transmission: Inhalation of aerosols containing contaminated urine, feces and body fluids
- ~50% of patients asymptomatic
- Symptoms: Rapid onset of fever (1-2 weeks after), severe headache, cough, flu-like symptoms without rash
- Resolves without treatment in ~50%
- 30-50% go on to develop pneumonia
- Abnormal liver tests common --> Can lead to hepatitis
- ~5% of patients go on to develop chronic Q fever
|
|
|
Term
Diagnosis, Treatment and Prevention of Coxiella burnetii |
|
Definition
- Diagnosis: Serology
- Treatment: Doxycycline for severe cases, otherwise nothing
- Prevention: Avoid exposure, good hygiene, disinfection, avoid unpasturized milk, and screen farm animals
- Vaccines available in other countries --> NOT in US |
|
|
Term
|
Definition
- G- obligate intracellular pathogen --> Forms morulae inside monocytes
- Vector: Lone-star tick
- Reservoir: White-tailed deer
- Human Monocytic Ehrlichiosis (HME)
- Usually acute but can become chronic
- Incubation: 1-2 weeks
- Symptoms: Flu-like symptoms with leukopenia, thrombocytopenia, and elevated ALT/AST
- Rash seen in ~30% of patients
- Similar to RMSF in presentation and location
- Disease severity: ~50% of patients require hospitalization --> Mortality of 2-3%
- Risk factors: Old age and immunocompromised |
|
|
Term
Anaplasma phagocytophilum |
|
Definition
- G- obligate intracellular pathogen --> Forms morulae in granulocytes
- Causes Human Granulocytic Anaplasmosis (HGA)
- Vector: Ixodes scaplaris (tick)
- Reservoir: Small mammals
- Incubation: 1-2 weeks
- Usually acute but can become chronic
- Symptoms: Fever, flu-like symptoms with leukopenia, thrombocytopenia, and elevated ALT
- Rash uncommon
- Severity of disease: ~50% require hospitalization and <1% mortality
- Similar presentation and location as RMSF and HME
- Risk factors: Old age and immunocompromised |
|
|
Term
Diagnosis, Treatment and Prevention of Ehrlichia & Anaplasma |
|
Definition
- Diagnosis: PCR
- Treatment: Doxycycline
- Prevention: Avoid ticks, tick inspections, etc |
|
|
Term
|
Definition
- Spirochete causing leptospirosis
- Transmission: Exposure to contaminated water
- Entry: Ingestion or through skin breaks
- Symptoms: Variable with abrupt onset
- Incubation: 2-4 days
- Some recurring disease is possible --> Weil's disease is most severe
- Can cause endothelial cells demage |
|
|
Term
Treatment and Prevention of Leptospira interrogans |
|
Definition
- Treatment: Usually self-limiting in healthy patients, treated with doxycyclin or penicillin otherwise
- Prevention: Avoid exposure and vaccinate animals
- No human vaccine |
|
|
Term
|
Definition
- Motile (flagella) spirochete causing Relapsing fever
- Can either be tick or louse born
- Tick-borne (endemic): Tick --> Rodent in West
- Louse-born (epidemic): Human lice --> War regions/refugee camps
- Incubation: ~7 days
- Symptoms: 3 day fever that goes away for the next 7 days
- Re-infection possible due to antigenic variation
- Usually resolves after 1-4 episodes
- Higher motality in LBRF |
|
|
Term
Diagnosis, Treatment and Prevention of Borrelia recurrentis |
|
Definition
- Diagnosis: Lab tests difficult and slow --> Presentation/history
- Treatment: Empirically with tetracylcin
- Prevention: Avoid exposure with vectors |
|
|
Term
|
Definition
- All G- rods/coccobacilli
1. Brucella spp. --> Brucellosis via pigs, cattle, goats and sheep --> From dairy products
2. Francisella tularensis --> Tularemia via rabbits, deer, and ticks --> From antimal tissue contact
3. Yersina pestis --> Plague via fleas from rodents
4. Pasteurella multocida --> Cellulitis via cat and dog bites (normal flora) |
|
|
Term
|
Definition
- Viral: Deer Tick Virus --> Rare cause of fatal encephalitis
- Rickettsial
- Ehrlichia
- Anaplasma
- Lyme
- Relapsing Fever
- Tularemia
- Babesiosis |
|
|
Term
|
Definition
- Spirochete that causes Lyme disease in the US
- B. garinii and azfelii are causative agents in Europe
- Incidence of Lyme increased in this area due to deforestation and increased prevalence of deer
- Ticks got to the area on migrating birds |
|
|
Term
|
Definition
- Ixodes scapularis --> New England
- Ixodes pacificus
- Ixodes ricinus
- Ixodes persulcatus
- Ixodes scapularis also carries anaplasma, causing HGA, and Babesia microti, causing Babesiosis |
|
|
Term
|
Definition
- Adult ticks lay eggs in the fall
- Eggs hatch in the spring
- Larvae attach and feed on rodents
- Spirochete grows in within the white footed mouse
- Larvae obtain spirochete when they bite mouse
- Ticks now carry spirochete
- Ticks can bite humans for next meal and transmit spirochete to human |
|
|
Term
|
Definition
- Erythema migrans: Classically represented as bullseye
- Usually presents as solid red rash bigger than a tennis ball and smaller than a basketball
- Usually found behind the knee, lower back, groin or armpit
- 25% of times the rash can disseminate to develop multiple lesions
- Even though it looks like cellulitis, IT IS NOT!!
- Erythema migrans can occassionally become necrotic
- Other symptoms: Flu-like symptoms, arthritis, carditis, and neurological symptoms
- Arthritis usually presents weeks to months after bite
- Carditis --> 3rd degree heart block |
|
|
Term
Neurological Symptoms with Lyme |
|
Definition
- Meningioencepalitis
- Bell's Palsy --> Usually early and bilateral!!
- Radiculitis
- Peripheral neuropathy --> Uncommon
- Encephalopathy |
|
|
Term
Diagnostic Testing for Lyme |
|
Definition
- Two step test
- Begins with ELISA --> Then western blot for Lyme specific proteins
- Not very useful --> Lots of false positives
- False positives with lupus, RA and syphilis also
- Avoid use with arthralgia, myalgia, fatigue, and palpations --> Non-specific complaints
- Western blot: Tests IgM and IgG for proteins |
|
|
Term
Uses for Diagnostic Panels for Lyme |
|
Definition
1. Erythema migrans
2. Early disseminated Lyme
3. Lyme arthritis
4. False positives possible with other conditions --> Lupus, RA and syphilis |
|
|
Term
Treatment of Lyme Disease |
|
Definition
- Oral: Doxycyclin, amoxicillin, erythromycin and penicillin
- IV: Ceftriaxone and penicillin
- Others: Azithromycin and cefuroxime
- Treatment for Erythema migrans: 10 days of doxycyclin therapy
- Advese effects: Photosensitivity!!
- Treat empirically even without positive test!!!! |
|
|
Term
Antibiotics and Chronic Lyme |
|
Definition
- No change in status with placebo and antibiotic patients
- Cause of chronic Lyme is not treated by antibiotics!!
- No evidence that spirochete actually persists |
|
|
Term
|
Definition
- Keep out of high grass
- Wear proper clothing --> Light clothing (see ticks)
- Use DEET on lower legs
- Tick checks
- Properly remove ticks if found
- Avoid prophylactic antibiotics
- Still only 3% chance of getting infected when bit by a tick
- No longer a vaccine |
|
|
Term
Factors to Consider for Antibiotic Therapy |
|
Definition
1. Is it an infection?
2. Is it bacterial?
3. How sick is the patient (IV vs. PO)?
4. How quickly does patient need to be started on treatment?
5. What are the consequences if you make a mistake?
6. Site of infection --> Endogenous vs. exogenous
7. What are the most common infections in this host?
8. Host: Age, medical history, social history, etc
9. Bacteriocidal vs. bacteriostatic
10. Distribution of drug of choice into infection site |
|
|
Term
Antibiotic Treatment of Endocarditis |
|
Definition
- Need bacteriocidal agent!! --> Vancomycin up front
- S. aureus most common --> High resistance!!
- Anaerobes possible --> Patients with gingivitis and poor dental hygiene
- S. epidermidis and G- possible with valve replacement |
|
|
Term
Antibiotic Treatment of Upper Lobe Pneumonia |
|
Definition
- S. pneumonia and atypicals possible
- 3rd gen cephalosporin (ceftraxone) and azithromycin
- Atypicals: Fluroquinolone or macrolide
1. Levofloxacin is better than azithromycin --> Higher serum levels for seriously ill patients
2. G- possible (E. coli & Klebsiella) in patients with diabetes
- Don't treat lung infection from Klebsiella with gentamicin --> Poor penetrance into lungs and poor activity with acidic pH and anaerobic conditions
3. HIV+ with CD4 of 25 --> S. pneumonia and fungal infections (very severe!!)
- CD4 of 500 --> S. pneumo and mycobacteria but NOT fungal |
|
|
Term
Antibiotic Therapy of Meningitis |
|
Definition
- Most common: S. pneumoniae and N. meningitidis in 18-50 y.o --> Different for different age groups
- Treatment: Ceftriaxone and vancomycin to cover possible resistance --> Treat quickly!!!
1. Immunosuppresion/lupus: Listeria and G- causes can happen --> Vancomycin
2. Shunt for hydrocephalus: S. epidermidis and shunt associated bacteria --> Vancomycin
- Higher dose of ceftriaxone (2 g) and shorter interval (12 hours) --> Needed to get proper MIC in CSF
- Patients sometimes come in without meningismis (neck stiffness) --> Can just disseminate and progress that quickly!! |
|
|
Term
Antibiotic Therapy for Diabetic Ulcer |
|
Definition
- Commonly caused by group B strep and S. aureus
- Oxacyclin/penicillin or ceftriaxone therapy
- Ulcers re-occur commonly --> Increased resistance with every re-appearance
- Strep and Staph still cause early reoccurances but others can come in afterwards |
|
|
Term
|
Definition
- Empiric: Treating for your best guess
- Definitive: Adjustment of therapy due to results of cultures/serolgy
- Prophylactic: Used in prevention of disease --> Common peri-surgically
- Always consider resistance --> De-escalate treatment whenever you can!!! |
|
|
Term
Antibiotic Treatment of UTIs |
|
Definition
- Usually caused by G- bacilli/rods --> Often motile (E. coli)
- Determined by finding bacteria and leukocytes in urine
- Treatment: Levofloxacin because fluroquinolones are good against G- bacteria
- If reccurence occurs, prophylactic treatment can be used if reccurrence is situational |
|
|
Term
|
Definition
- Helminths
- Nematodes (Roundworms)
- Cestodes (Flat worms)
- Trematodes (Flukes)
- Transmission: Oral, inoculation, and direct penetration through skin |
|
|
Term
|
Definition
- Stage transformation: Transcriptional activation
- Adult (definitive) vs. Larval (Intermediate)
- Enormous variation in clinical presentation
- Most infections are asymptomatic
- Local vs. systemic effects
- Diagnosis: Visualize parasite in samples, clinical syndrome and PCR and DNA probes
- Treatment: Ranges from highly effective to no treatment |
|
|
Term
|
Definition
- Tissue protozoan parasite --> Toxoplasma gondii
- Worldwide problem --> Not so much in the US
- Seroprevalance >50% at adolescence in Western Europe, Africa, South and Central America
- Only 14-27% seroprevalence in the US
- Infection rate increases with age and differs regionally |
|
|
Term
Life Cycle of Toxoplasmosis |
|
Definition
- Oocytes are ingested by mice or small rodent
- Pseudocyst grows in the tissues of the mouse
- Mouse eaten by cat --> Undergoes sexual cycle in cat
- Cats excrete occytes in feces
- Pseudocysts can either be ingested from undercooked or raw meat
- Oocytes can be transmitted through feces
- Become tachyzoites in human host
- Tachyzoites infect the liver cells
- Infected macrophages distribute tachyzoites throughout the body
- Pseudocysts develop in the tissues as a response to the acquired immunity
- Infections: Brain lesions, chorioretinitis, lyphadenitis and hepatitis |
|
|
Term
Transmission of Toxoplasmosis |
|
Definition
- Ingestion of oocytes: Poor hygiene, contaminated water, contact with contaminated soil, and close contact with cats
- Ingestion of tissue cysts: Raw or uncooked lamb, beef or pork
- Also transmitted from goat, deer, bear, moose, elk, and kangaroo meat |
|
|
Term
|
Definition
- Shed by cats in feces
- Excreted for 7-20 days after infection of cats
- Up to 10 million shed in a day
- Must sporulate in environment --> Takes 1-5 days
- Viable for up to 16 months in the soil
- Oocyst --> Contains two sporocysts containing four sporozoites
- Sporozoites actually infect body |
|
|
Term
Toxoplasmosis Tachyzoites |
|
Definition
- Hallmark of active infection
- Present in either primary or reactivated infections
- Must invade into cells
- Invades contiguous cells or is phagocytosed
- Transported to other areas in the body
- Protected by the parasitophorous vacuole (food vacuole) |
|
|
Term
|
Definition
- Can be up to 200 mm and contain 3,000 bradyzoites (organisms)
- Forms 1 week after infection
- Probably viable throughout host's life
- Grows in brain, eye, heart muscle and skeletal muscle
- Bradyzoites are periodically released from cyst --> Small inflammatory reaction and tissue destruction
- Causes more severe symptoms in immunocompromised patients |
|
|
Term
Immune Response in Toxoplasmosis |
|
Definition
- Parasites replicate and cause cell rupture without antibody production to infection
- Antibody production and binding to infected cells induces apoptosis |
|
|
Term
Clinical Presentation of Toxoplasmosis |
|
Definition
- Symptomatic in only 10-20% of people
- Incubation: 7-17 days
- Symptoms: Fever, lympadenopathy, myalgias, stiff neck, headache, and anorexia
- Rash, arthralgias and hepatomegaly are possible but less commmon
- Immunocompromised patients: Reactivation, encephalitis is most common but lung, retinal and heart infections are possible
- IgM antibodies are usually absent in immunocompromised patients |
|
|
Term
Ocular Toxoplasmosis Disease |
|
Definition
- Reactivation of in utero infection --> Mid 20s-30s
- Bilateral, old scars, involvement of macula
- 25% of posterior uveitis in the US --> 85% in Brazil
- Acquired disease is actually more common
- Retinochoroiditis with unilateral, painless, and focally necrotic retinal lesions
- Symptoms: Blurred vision, photophobia, and scotoma |
|
|
Term
Congenital and Newborn Toxoplasmosis |
|
Definition
- Newborn: Hydrocephalus, chorioretinitis, and intracerebral calcifications --> Highly variable symptoms, often missed
- Congenital: Primarily neurologic --> Retinochoroiditis, CSF problems, anemia, seizures, intracranial calcifications, hydropcephalus, microcephalus, and fever |
|
|
Term
Diagnosis of Toxoplasmosis |
|
Definition
- Isolate organism from culture
- Histology and immunoperoxidase staining
- PCR --> Crucial for intrauterine diagnosis
- Serology --> IgG and IgM levels but IgG is life-long so alone is useless
- Brain biopsy very uncommon but possible
- Brain scans --> Ring enhancing lesion!! |
|
|
Term
|
Definition
- Protozoa in the order of Kinetoplastida
- Live in macrophages --> Intracellular amastigotes
- Promastigotes: Extracellular in sandfly gut
- Visceral, cutaneous, and mucocutaneous types
- Sandfly: Breeds in cracks in house walls, trash, and piles of rubble |
|
|
Term
|
Definition
- 2 million cases world wide (endemic)
- Reservoirs: Dogs, rodents and other small mammals
- Affects primarily children and young adults
- Risk factors: Malnutrition and HIV
- Pathogenesis: Replicates in quiescent macrophages but killed by activated macrophages --> Th1 immune response initiated via g-interferon and IL-12 |
|
|
Term
|
Definition
1. Human Stages
- Sandfly takes blood meal from human
- Promastigotes phagocytosed by macrophages
- Become amastigotes --> Multiple
- Sandfly takes another blood meal from hum and ingests amastigotes
2. Sandfly Stages
- Ingestion of parasitized macrophage
- Amastigotes transform back into promastigotes
- Promastigotes divide and migrate to salivary gland
- Sandfly takes another bite |
|
|
Term
|
Definition
- Leishmania donovani
- Kala-azar --> Hindi for black sickness/fever
- Amastigotes disseminate to liver, splee, and bone
- Symptoms: Hypergammaglobulinemia, hepatosplenomegaly, weakness, fever, and pancytopenia
- Protective Th1 response is reduced or absent --> No DTH response to leishmanin skin test
- Cannot clear infection --> Cell death occurs
- Incubation: 3-8 months
- Complications: Bleeding, secondary bacterial infections, sepsis, edema and possibly death
- Post-kala azar derman leishmaniasis (PKDL): Relapse of disease in 2-20%, responds to treatment |
|
|
Term
Diagnosis of Visceral Leishmaniasis |
|
Definition
- Demonstration of amastigotes in tissue (Giemsa stain)
- Isolation of Leishmania in culture
- Bone marrow aspirate --> Easiest but less sensitive
- Splenic aspirate --> Difficult and dangerous but most sensitive |
|
|
Term
|
Definition
- Leishmania tropica
- "Pizza-like" lesion --> Mixed acute and chronic inflammatory response
- Begins as papule --> Ulcerates --> Shallow and well defined
- Th1 response leads to scar formation and immunity
- Incubation: 2 weeks to several months
- Satellite lesions possible
- Secondary Staph or Strep infections may occur --> Open ulcer
- Diagnosis: Biopsy the border of lesion or PCR |
|
|
Term
Mucocutaneous Leishmaniasis |
|
Definition
- Leishmania braziliensis
- Prevalent in Central and South America
- Hematogenous or lymphatic dissemination of parasite
- Caused by members of Vianna subgenus
- Disseminates from skin to naso or oropharynx
- Usually occurs several years after CL in <5%
- Cure rates of 10-63% for advanced disease with antimony drugs |
|
|
Term
Prevention and Control of Leishmaniasis |
|
Definition
- Avoid areas where vector is found
- Spray homes with insecticides
- Use insecticide-treated bednets and curtains
- Vaccine development in progress |
|
|
Term
|
Definition
- Chagas' Disease --> Caused by Trypanosoma cruzi
- 16-18 million people are seropositive in Latin America --> Bolivia has highest rate of seroprevalence
- Most cases from central and southern Brazil
- 100,000 infected people in US --> Most don't know!!
- Reservoirs: Dogs, cats, guinae pigs and peridomiciliary rodents
- Vectors: Reduviid bugs
- Transmission: Congenital, blood transfusions, contaminated food, and laboratory accidents |
|
|
Term
Life Cycle of Trypanosoma cruzi |
|
Definition
- Trypomastigote ingested by human
- Turns into amastigotes in tissues
- Excreted in feces
- Ingestion of amastigotes by vector
- Turns to epimastigote in midgut of reduviid bug
- Epimastigotes multiply --> Turns to metacyclic trypomastigote
- Metacyclic trypomastigote becomes infective |
|
|
Term
Clincal Manifestations of Chagas' Disease |
|
Definition
- Acute: Mostly asymptomatic, 10-20% with non-localizing febrile syndrome, and <5% have severe illness with acute heart failure and meningoencephalitis
- Most severe in children
- Anemia, lymphocytosis, and modest increases in ALT/AST are common
- Chagoma: Inoculation granuloma/Romana's Sign --> Bipalpebral, unilateral chronic edema of the eye with bug feces rubbed in eye --> Edema lasts days to weeks
- Indeterminate Phase: Asymptomatic stage
- Chronic Disease --> Cardiomyopathy and Megasyndromes (megaesophagus and megacolon) |
|
|
Term
Diagnosis and Prevention of Chagas' Disease |
|
Definition
- Giema stained thick and thin blood smears
- Trypomastigotes in CSF, pericardial fluid, biopsies and bone marrow
- Xenodiagnosis for indeterminate or chronic
- Serology via ELISA --> IgG serologies
- Serology false positives due to syphilis, Leishmania, and malaria
- Prevention: Education, bug and nest control, and proper home construction |
|
|
Term
|
Definition
- African sleeping sickness
- Trypanosoma brucei rhodiense --> Eastern Africa
- T. brucei gambiense in Western and Central Africa
- Vector: Tsetse fly
- Symptoms: Chancre at site of infection, fever, rash, headache, lymphadenopathy, and altered mental status
- Incubation: 2-3 weeks
- Invades lymphoid-macrophage system
- Late symptoms: Anorexia, weight loss, lassitude, fatigue, stupor, coma and death
- Diagnosis: History, clinical findings, and demonstration of trypanosomes in Giemsa-stained blood smears |
|
|
Term
Malarial Transmission and Epidemiology |
|
Definition
- Only Anopheles mosquitoes can transmit --> >60 species and exceptionally diverse
- Malarial parasites: P. vivax, P. ovale, P. malariae, P. falciparum, and P. knowlesi
- Other modes of transmission: Vertical, blood transfusions, needles sticks and sharing needles
- ~500 million cases/year --> ~800 thousand deaths/year
- Sickle cell anemia/trait, Thallassemia and P. falciparum immunity
- Duffy antigen negativity and P. vivax immunity in West Africa |
|
|
Term
|
Definition
1. P. vivax --> Benign tertian, everywhere except Western Africa --> Dormant stage, relapsing, sulfa drug resistance, 12-14 day incubation, 48 hour fever cycle and requires Duffy antigen
2. P. ovale --> Benign tertian, only West and Central Africa, dormant stage, relapsing, low risk of death, minimal resistance, 12-14 day incubation, 48 hour fever cycle and similar to P. vivax
3. P. malariae --> Quartan, tropical areas, no dormant stage, chronic but never relapsing, minimal resistance, 34 day incubation, and 72 hour fever cycle
4. P. falciparum --> Malignant tertian, tropical areas, no dormant stage, acute illness without relapses, kills millions, high resistance 12-24 day incubation, and 48 hour asynchronous fever cycle
5. P. knowlesi --> SE asia only, no dormant stage, acute and never relapsing, low risk of death, 12-14 day incubation, and 24 hour fever cycle |
|
|
Term
Clinical Presentation of Malaria |
|
Definition
- Non-specific malaise
- Paroxysmal fever vs. intense sweating --> Abrupt onset of chills/shaking and high fever with headache and diarrhea
- Varying patterns of febrile and afebrile stages
- Uncomplicated malaria: Fever and melaise
- Complicated malaria: Hemolytic anemia, severe hypoglycemia, occlusion of microcirculation, and cerebral malaria
- Treatments can further lower blood sugar via insulin spike!!
- Long term: Growth failure/stunting, impaired mental development, and immunocompromised state |
|
|
Term
|
Definition
1. Schizogony: Makes schizonts in humans (7 days)
- Sporozoites injected into human by female mosquito
- Migrates to liver to infect hepatocytes --> Takes about 20 minutes
- Becomes either hypnozoite (dormant) or merozoite
- Micromerozoites are released into circulation
- Merozoites invade RBCs
- Merozoites replicate --> Burst out of RBC (Fever)
- Merozoites become male or female gametocytes
- Gametocytes taken up again by female mosquito
2. Sporogony: Makes sporozoites in mosquito (10-14 days)
- Mosquito injects gametocytes (needs both male and female)
- Zygote results --> Invades gut of mosquito --> Oocysts
- Oocysts migrate to salivary glands and form sporozoites |
|
|
Term
Replication Phases of Malaria |
|
Definition
- Sexual: Genetic recombination --> Diversity!!
- Asexual: Continuous random variation --> Evolution of cell surface antigens and evasion of the immune system |
|
|
Term
Treatment and Vaccine Targets for Malaria |
|
Definition
- 8-amino quinolines --> Inhibit liver infection
- Chloroquine, amodiaquine, quinine, mefloquine, etc --> Inhibits replication in RBCs
- SP causes a brief increase in gametocytes --> Interesting side effect
- Vaccines: Sporozoite, merozoite, and gametocyte vaccines in development |
|
|
Term
|
Definition
- Sickle cell trait, Thallassemia, and duffy antigen negative
- Resistance is rarely complete --> Strain and species specific
- Depends on continuous exposure!! --> Transient
- Immune system can learn to tolerate parasites even when unable to eliminate --> Tolerates symptoms |
|
|
Term
|
Definition
- Microscopy is still gold standard --> Blood smears
- Rapid diagnostic assays (dipsticks) --> HRP2 antigens, etc
- PCR --> Accurate but expensive!!
- Clinical diagnosis but very innacurate! |
|
|
Term
|
Definition
- Thick smear: Stacked RBCs, lysed with methanol and stained for pathogens --> Sensitive but cannot speciate or quantify intesity
- Thin smear: Monolayer of RBCs, can speciate and quantify but poor sensitivity and takes alot of time
- >5% parasitemia --> P. falciparum!!
- P. falciparum can infect all RBC (>1 parasite/RBC), P. ovale/vivax can only infect reticulocytes
- Banana shaped gametocytes --> P. falciparum!! |
|
|
Term
Malarial Prevention and Treatment |
|
Definition
- Vector Control: Indoor residual spraying, insecticide treated bednets, and area spraying of DDT
- Personal Control: Chemo-prophylaxis, mosquito repelleants, behavioral changes, and vaccines
- Treatment: Quinine, quinidine, chloroquine, malarone, doxycycline, primaquine, mefloquine, and CoArtem
- Some meds are only for treatment and some are only for prophylaxis
- Combination therapy: Reduces resistance and quick vs. slow killing |
|
|
Term
|
Definition
- Babesia microti --> Looks ALOT like malaria on smears!!
- Vector: Ixodes scapularis (Lyme and HMA carrier)
- Reservoir: Rodent and cattle --> Different strains
- Also transplacental and blood transfusion transmission
- Symptoms: Asymptomatic or mild fever, chills, malaise, anorexia, fatigue, headache, myalgias, N/V, adbominal pain, jaundice, etc
- Severe disease: Immunocompromised or patients who have had their spleens removed
- Incubation: 1-6 weeks but 6-9 weeks in transfusion transmissions
- Incidence: Highest in MA and New England |
|
|
Term
|
Definition
- Human/rodent cycle: Sporozoites introduced into host, becomes trophozoites, infects RBCs and becomes merozoite
- Merozoite becomes gamete in reservoir/rodent
- Tick cycle: Tick ingests gametes, fertilization occurs in gut, becomes ookinete, enters salivary gland, undergoes sporogony, sporozoites produced in salivary gland |
|
|
Term
|
Definition
- Lab findings: Anemia with hemolysis, thrombocytopenia, proteinuria, elevated ALT/AST, and increased bilirubin
- "Maltese Cross" on thick and thin smears
- IgG detection via indirect IF
- PCR |
|
|
Term
Drug Prevention and Treatment of Malaria |
|
Definition
- Most important factor is the infecting species --> Is it P. falciparum or not??
- Immune and genetic status of the host affects severity
- Prevention of mosquito bites and chemoprophylaxis
- Treatment seeks to inhibit parasite multiplication and development
- Drugs: Chloroquine, mefloquine, atovaquone/proguanil, primaquine, and doxycycline |
|
|
Term
|
Definition
1. Blood schizonticidal agents --> Against blood stage parasites
2. Tissue schizonticidal agents --> Against liver stage parasites
3. Prophylaxis --> Prevent blood stream infection by inhibiting replication of liver-stage parasites |
|
|
Term
Malarial Blood Schizonticidal Agents |
|
Definition
- 4-aminoquinolines (chloroquine)
- Quinoline-methanols (mefloquine)
- Hydroxynapthoquinone (atovaquone)
- Folate antagonists: DHFR inhibition (proguanil) and PABA competition (sulfonamides/sulfones)
- Doxycylcine: Protein synthesis inhibitor
- Artemisin derivatives (artemether, artesunate) |
|
|
Term
|
Definition
- 4-aminoquinoline
- Active against erythrocytic schizonts of P. malariae and ovale, most P.vivax, and P. falciparum
- Activity: Large ring forms and mature trophozoite stages
- Given orally, well absorbed, widely distrubted, and very long elimination
- Weekly dosing --> Great for prophylaxis
- Target: Process of Hb digestion in food vacuole
- Resistance: Interference with chloroquine accumulation and efflux mechanisms --> High for P. falciparum
- Adverse effects: headache, GI upset, pruritus, and visual problems with prolongued use (5 years)
- Can be used in pregnancy!! |
|
|
Term
|
Definition
- Artemether: Endoperoxide moiety
- Lumefantrine: Inhibits formation of beta-hematin
- Target: Nucleic acid and protein synthesis
- Use: Acute and uncomplicated P. falciparum infection
- Highly bound to serum proteins
- Artemisinin/artemether has short half-life (2 hours) and lumefantrine has 3-6 day half-life
- Not suitable for prophylaxis!!! |
|
|
Term
|
Definition
- Hydroxynapthoquinone
- Target: Electron transport
- Highly lipophilic --> 2-3 day half-life and poor CNS penetration
- Uses: Broad spectrum for antiprotozoal infections, P. falciparum and maybe P. vivax
- Resistance: Develops rapidly when used alone
- Usually used in combination with proguanil (Malarone) |
|
|
Term
|
Definition
- Folate antagonist --> Inhibits dihydrofolate reductase
- Poorly absorbed
- Short half-life
- Slow schizonticidal activity in erythrocytic forms
- Activity: Sporozoites and hepatic forms of P. falciparum
- Combination with atovaquone (Malarone) --> Daily dosing for prophylaxis and treatment |
|
|
Term
|
Definition
- Flourinated 4-quinoline methanol
- Activity: chloroquine-resistant P. falciparum
- Moderately well absorbed
- Extensively distributed
- Slowly eliminated --> Weekly dosing
- Highly bound to plasma proteins
- Hepatic clearance to inactive metabolites
- Target unclear
- Resistance: P. falciparum strains
- Uses: Prophylaxis and treatment of uncomplicated malaria
- Adverse Effects: GI disturbances, headache, insomnia, abnormal dreams, and neuropsychiatric events
- Contraindications: Psychiatric illness, cardiac arrhythmia and seizures
- May be used in pregnancy!! |
|
|
Term
|
Definition
- 8-aminoquinolone --> Tissue schizonticidal drug
- Activity: Exoerythrocytic forms of P. ovalen and vivax and gametocytes
- Target: Mitochondrial function
- Use: Treatment of relapsing P. vivax and ovale and prophylaxis
- Contraindications: G6PD deficiency --> Hemolysis!!
- Usually well tolerated |
|
|
Term
Other Medications for Malaria |
|
Definition
- Doxycycline: Protein synthesis inhibitor --> Not for patients <8 years
- Quinine and quinidine (Cinchona alkaloids): Parenteral (IV) administration for severe malaria --> Treatment only and significant toxicity
- Parenteral artesunate: Only available from the CDC for severe malaria |
|
|
Term
|
Definition
- GI luminal parasites
- Giardia lamblia, Entamoeba histolytica, Isospara belli, Cyclospora cayetanensis, Cryptosporidium parvum, and Trichomonas vaginalis
- Rarely invasive but E. histolytica can disseminate
- Therapy directed at the site of infection |
|
|
Term
Treatment of Luminal Protozoa |
|
Definition
- Nitroimidazoles --> Metronidazole and tinidazole
- Aminoglycosides --> Paromomycin
- Folate antagonist: Trimethoprim/Sulfamethoxazone
- Thiazolide --> Nitazoxanide |
|
|
Term
|
Definition
- Activity: Many protozoa
- Use: Bacterial infections, invasive amebiasis, giardiasis, and trichomoniasis
- Administration: IV and PO
- Metabolism: Hepatic
- Mechanism: Electron sink --> Damages DNA
- Side effects: GI distress, dysgeusia, and dizziness
- Adverse effect: Disulfiram-like effect with alcohol and potentiates warfarin
- May be used after first trimester of pregnancy |
|
|
Term
|
Definition
- Aminoglycoside
- Administration: orally --> Poor absorption
- Side effects: GI symptoms
- Can be ototoxic or nephorotoxic in renal failure patients
- Uses: Giardia, Cryptosporidium, and Entamoeba cysts |
|
|
Term
|
Definition
- Licensed in 2002 to treat Giardia and Cryptosporidium diarrhea
- Absorption: Well absorbed in GI
- Well tolerated but sometimes mild/transient GI symptoms
- Uses: Broad antiprotozoal and antihelminthic activity |
|
|
Term
|
Definition
1. GI and tissue nematodes (roundworms)
- Ascaris lumbricoides
- Enterobius vermicularis
- A.duodenale/ N. americanus
2. Trematodes (flukes)
- Schistosoma spp.
- Clonorchis/Opisthorchis
3. Cestodes (Flatworms)
- Taenia spp.
- Echinococcus spp.
|
|
|
Term
|
Definition
- Agents listed for US use
- Benzimidazoles --> Albendazole and mebendazole
- Macrocyclic lactones --> Ivermectin
- Isoquinoline-pyrazine --> Praziquantel |
|
|
Term
|
Definition
- Albendazole (mebendazole no longer available in the US)
- Use: Broad spectrum for helminth infections
- Mechanism: Inhibition of microtubule polymerization, binds to B-tubulin
- Active against larvae, adult and egg stages
- Results in immobilization of parasite over days
- Not recommended during pregnancy |
|
|
Term
|
Definition
- Absorption: Variable but increased with fatty meal
- Metabolism: Rapid hepatic metabolism
- Distribution: Well distributed including into cysts
- Elimination: Renal excretion of metabolites
- Low toxicity --> GI upset
- Potent anti-helminthic activity |
|
|
Term
|
Definition
- Macrocyclic lactone
- Use: Nematodes and ectoparasites (strongyloides, onchocerciasis, and scabies)
- Mechanism: Binds chloride ion channels to hyperpolarize nerve cells and kill parasite
- Administration: PO, well absorbed and long half-life
- Toxicity: Low but may trigger allergic reaction
- Safe during pregnancy |
|
|
Term
|
Definition
- Isoquinoline-pyrazine
- Mechanism: Increases membrane permeability to cations --> Spastic paralysis with low and tegument damage with high doses
- Administration: Well absorbed orally
- Metabolism: Hepatic metabolism to inactive metabolites
- Interactions: Modified by P450 drugs (inducers or inhibitors)
- Toxicity: Low --> Safe during pregnancy
- Use: Schistosoma spp, tapeworm, and fluke infections |
|
|
Term
Systemic Inflammatory Response Syndrome |
|
Definition
- 2 or more of the following criteria must be fulfilled:
1. Temperature >38C or <36C
2. Heart reate > 90 beats/minute
3. Respiratory rate > 20 or PaCO2 < 32mmHg
4. WBC >12K or <4K/mm3, or >10% bands
- Causes: Bacterial infections, non-infectious pancreatitis, major trauma, viral infections, and fungal infections |
|
|
Term
|
Definition
- SIRS due to an infection
- Septic shock --> Shock due to sepsis
- Severe sepsis --> Sepsis with failure of at least one organ system
- 750 million patient discharges --> 8.7% increase/year
- More commonly caused by G+ than G-
- Highest mortality among black men
- Little improvement in mortality since the advent of antibiotics --> 24% 28 day mortality and 33% 90 day mortality
- Due to dysfunctional inflammation and clotting systems |
|
|
Term
|
Definition
- Hematoma --> Hemorrhage within a space
- Bruises --> Petechiae, purpura and ecchymosis
- Petechiae --> Small clots all over the place under the skin
- Ecchymosis --> Bruise |
|
|
Term
|
Definition
- Clotted blood within the vascular space
- Composed of cellular elements from the blood
- Includes platelets, RBCs, WBCs and proteins from coagulation cascade
- Arterial: Arises at site of injury --> Lines of Zahn (layers of RBCs and then platelets/fibrin)
- Venous: Arises at site of stasis --> Less firmly attached and usually in LE |
|
|
Term
Normal Hemostasis After Injury |
|
Definition
1. Vasoconstriction
2. Primary hemostasis
3. Secondary hemostasis
4. Thrombosis and anti-thrombotic events |
|
|
Term
Vasoconstriction After Injury |
|
Definition
- Smooth muscle cells contract
- Blood and platelets are now exposed to underlying ECM |
|
|
Term
|
Definition
- Platelet adhesion to ECM via von Willebrand's Factor
- Granule release from platelets
- Platelets aggregate to form primary clot
- Endothelial cells begin to express tissue factor
- Tissue factor activates the clotting cascade |
|
|
Term
Secondary Hemostatic Plug |
|
Definition
- Clotting cascade produces fibrin which binds to the primary plug
- Fibrin eventually completely replaces the primary plug of platelets and ECM |
|
|
Term
Thrombotic and Anti-thrombotic Events after Injury |
|
Definition
- After secondary plug forms, anti-thrombotic events begin
- Helps to allow tissue to be repaired and have resident tissue replace damaged tissue and clot
- Tissue plasminogen activator --> Cleaves fibrin |
|
|
Term
Endothelial Cells and Injury |
|
Definition
- Usually have anti-thrombotic properties
1. Anti-platelet activity --> Provides physical barrier from ECM and produce NO and prostacylcin PGI2 which inhibit platelets
2. Anti-coagulant activity --> Heparin-like molecules, thrombomodulin, and tissue factor pathway inhibitor
3. Fibrinolytic effects --> Tissue type plasminogen activator |
|
|
Term
Anti-Thrombotic Mediators |
|
Definition
1. Heparin-like molecules --> Binds anti-thrombin III and inactivates thrombin and coagulation factors
2. Plasmin --> Breaks down fibrin strands
3. Plasminogen Activator --> Activates plasmin
4. Thrombomodulin --> Binds thrombin --> Activates Protein C
5. Tissue Factor Pathway Inhibitor --> Inactivates factors VIIa and Xa
6. Protein C and S --> Inactivates Factor Va and VIIIa |
|
|
Term
Pro-Thrombotic Effects of Endothelial Cells |
|
Definition
1. von Willebrand Factor: Binds platelets to underlying ECM (collagen)
2. Tissue factor: Activates clotting cascade
3. Plasminogen Activator Inhibitors: Decreases fibrinolysis
4. Thrombin: cleaves fibrinogen to produce fibrin |
|
|
Term
Platelets and Clot Formation |
|
Definition
1. Adhesion: With collagen and vWF
2. Secretion: Ca++ and ADP
3. Aggregation: ADP and Thromboxane A2
- Clopidogrel (drug) blocks ADP binding to receptors to prevent thrombus formation |
|
|
Term
|
Definition
- Each step requires co-factor and calcium
- Uses phospholipid complexes
- Factor II (prothrombin) is activated by factor Va + Xa on cell phospholipid membrane
- Factor IIa (thrombin)
- Cleaves Factor I (fibrinogen) to Factor Ia (fibrin)
- Natural Anticoagulants: Anti-thrombins, Protein C, Protein S, and Tissue Factor Pathway Inhibitor |
|
|
Term
|
Definition
- Plasminogen: Inactive plasmin precursor
- Plasmin: Interferes with fibrin polymerization and breaks down fibrin
- Plasminogen activators: Turn plasminogen into plasmin |
|
|
Term
|
Definition
- Dysfunctional coagulation in sepsis
- Can lead to disseminated intravascular coagulation (DIC) --> Blood clots where it's not supposed to and doesn't where it should
- Activated Protein C (aPC) was approved for sepsis treatment --> Withdrawn Oct 2011 because it was ineffective |
|
|
Term
Events Favoring Thrombus Formation |
|
Definition
- Endothelial cell injury --> Complete or partial
- Abnormal blood flow --> Turbulent or sluggish
- Hypercoaguable state --> Genetic or acquired |
|
|
Term
|
Definition
- Propagate: Continue to grow, may eventually occlude
- Embolize: Break free and travel
- Dissolution: Lyse and degrade due to fibrinolysis
- Organize and recanalize: Granulation tissue shrinks the thrombus and new vascular channels form |
|
|
Term
|
Definition
- Pulmonary thromboemboli: Comes from deep veins in the pelvis or legs --> Can occlude large vessels
- Fat emboli: After long bone fractures --> Can occlude
- Air emboli: Decompression sickness
- Amniotic fluid emboli
- Septic emboli: Occlusion due to fragments of necrotic tissue |
|
|
Term
|
Definition
- Ischemic necrosis occurs due to loss of blood flow to an area of tissue
- Tissue generally appears wedge shaped
- Hemorrhagic --> In areas with dual blood supply or in areas that have been reperfused after occlusion of a vessel --> Appears bright red
- White/anemic --> Occlusion of an end arteriole |
|
|
Term
Sepsis, Inflammation and Inflammatory Mediators |
|
Definition
- Increased levels of TNF, IL-6 and IL-8
- Specific inhibitor therapy thought to improve survival --> Actually doesn't!!
- Cytokines may be markers rather than actual mediators of disease
- Lymphocytes: Accelerated apoptosis in several organs and blood
- Neutrophils: Decreased apoptosis so that they persist longer in the circulation --> Increased WBC count |
|
|
Term
Sepsis and Organ Dysfunction |
|
Definition
- Severe sepsis
- Some patients develop multisystem organ dysfunction (MODS)
- Eventual cause of death in septic patients is not well known |
|
|
Term
General Viral Characteristics |
|
Definition
- Obligate intracellular parasite
- Genome --> Either RNA or DNA based
- Capsid --> Protein coat made up of capsomeres
- Envelope --> Lipid bilayer acquired through budding
- Additional proteins may be packaged in with genome or in tegument --> Matrix proteins, kinase, etc
- Tegument --> Space between envelope and capsid
- Double capsid is also possible
- Viruses can lay down scaffolding proteins within cytoplasm or nucleus to assemble particles |
|
|
Term
|
Definition
- Made up of capsomeres
- Icosehedral: Spherical looking with 20 equilateral triangles, 12 verticies and 30 edges
- Helical: Tougher to see in LM and appears spherical due to envelope surrounding
- Complex: Much larger and more complex structure |
|
|
Term
|
Definition
- Primary cell culture --> original material
- Cell strains --> Subcultures with limited lifespan
- Cell lines --> Propogate indefinitely |
|
|
Term
|
Definition
- Cell damage seen on LM
- Cells detach from culture surface and die
- Cells appear circular and float around in solution |
|
|
Term
|
Definition
- Culturing technique
- Allows for quantification of infective virus --> Only way to do this!!
- Shows the area of dead cells from one viral particle
- Properties of media prevent the virus from infecting other cells except directly neighboring cells
- Viruses that escape into media will be bound by antibodies and killed |
|
|
Term
|
Definition
- Nuclear or cytoplasmic inclusion bodies
- Syncytia formation --> Multinucleated giant cell formation |
|
|
Term
Steps in Viral Replication |
|
Definition
1. Attachment (adsorption)
2. Penetration
3. Uncoating
4. Macromolecular synthesis
5. Assembly
6. Release
- Specifics vary for specific viral types, species, and strains |
|
|
Term
|
Definition
- Virus binds cell receptors on the surface --> Not tight binding
- Can target receptors that are cell/tissue specific
- Viral attachment proteins bind cell receptors |
|
|
Term
|
Definition
- Endocytosis --> Endosomes --> Out into cytoplasm and into nucleus if needed
- Enveloped viruses --> Membrane fusion --> Enters cytoplasm with capsid intact |
|
|
Term
|
Definition
- Releases genome
- Genome of virus can remain within capsid, bound to associated proteins or free
- Can remain in cytoplasm or travel into nucleus |
|
|
Term
Macromolecular Synthesis of Viruses |
|
Definition
- Depends on alot of cellular functions
- Small DNA viruses must use DNA polymerase and other cellular proteins
- Larger viruses have their own polymerases |
|
|
Term
|
Definition
- Once synthesis step has progressed enough, particles are assembled
- Alot of inefficiency --> Empty capsids, genome mutation, etc
- Only need 1 infectious particle to be released to further infect host |
|
|
Term
|
Definition
- Either through cell lysis or budding
- Budding --> Enveloped viruses
- Many viruses assemble particles just below membrane via a matrix protein
- Matrix protein is anchored right at membrane
- Budding can occur at either nuclear or cell membrane |
|
|
Term
|
Definition
1. Replication occurs in the nucleus
2. Synthesis of early mRNA for non-structural proteins --> Helps suppress cell processes and induce viral replication
3. Synthesis of early proteins in the cytoplasm --> Transported back into nucleus
4. DNA replication --> Use of host or viral DNA polymerase --> Typically semi-conservative
5. Synthesis of late mRNA
6. Synthesis of late proteins --> Structural --> Transported back into nucleus
- Exceptions: Parvoviruses and hepadnaviruses
|
|
|
Term
Replication of Herpes Simplex Virus |
|
Definition
- ds DNA virus --> Codes for 80-100 proteins
- Additional proteins are present in tegument
1. Virion binds specific receptors and fuses
2. Nucleocapsid and tegument released into cytoplasm
3. Immediate early mRNA production --> Produces regulatory proteins that are crucial for replication --> Upregulates viral genome
4. Capsid migrates to nucleus --> Through capsid and nuclear pore
5. DNA replication --> Late stage mRNA synthesis --> Assembly within nucleus --> ER --> Golgi --> Release
6. Release occurs through exocytosis or cell lysis |
|
|
Term
Replication of Hepadnaviruses |
|
Definition
- Ex. Hep B. --> circular dsDNA genome
- DNA is copied to RNA
- RNA is recopied into DNA via reverse trascriptase
- Analagous to retroviruses except genome is actually DNA
- This is done because genome is not complete --> One strand has a gap, while the other has a nick |
|
|
Term
Single-stranded RNA Viruses |
|
Definition
1. Replication occurs in the cytoplasm --> Can have either full or segmented RNA genomes
2. Positive stranded viral genomes --> Genome acts as mRNA --> Does not require virion-associated polymerase
- negative sense strand production serves as template for production of more positive sense strands for genome
- No clear distinction between early and late mRNA synthesis
- Ex. Picornavirus
3. Negative stranded viral genomes --> Need to produce positive strand for mRNA
- Requires virion-associated polymerase
- Positive sense strands serve as templates for new negative strands for genome
- No clear distinction between early and late mRNA synthesis
- Ex. Rhabdovirus |
|
|
Term
|
Definition
- 2 copies of ss (+) RNA
- Has virion associated reverse transcriptase (RNA --> DNA)
- Viral DNA then integrates into chromosomes via integrase protein (viral particle)
- Viral mRNAs and genomes produced via normal cell transcription, translation and replication
- Viral polypeptides must be cleaved to functional proteins |
|
|
Term
|
Definition
- ds RNA viruses --> Segmented genome
- Has virion-associated polymerase
- Genome is transcribed into monocistronic mRNA
- Each mRNA is translated into a single polypeptide
- Replication occurs conservatively --> Parent mRNA serves as the template for synthesis of complementary strands |
|
|
Term
|
Definition
- Genotype: Linear sequence
- Phenotype: Appearance and activity of virus
- Mutant
- Wild-type: Original strain
- Field or primary isolate: Strain directly taken from host (in vitro vs. in vivo)
- Reversion: Mutation that restores wild-type
- Mutation frequency: 1 in 10^8-10^11 nucleotides in DNA viruses and 1 in 10^3 - 10^5 nucleotides in RNA viruses
- Difference due to proof reading function of DNA polymerase vs. RNA polymerase |
|
|
Term
Interaction Between Viruses |
|
Definition
1. Recombination: Exchange of nucleic acid sequences between co-infecting viruses
2. Reassortment: Exchange between co-infecting viruses with segmented genomes
3. Complementation: No exchange of nucleic acid sequences but phenotype changed
- Re-establishment of wild-type possible in recombination and reassortment but NOT complementation
4. Viral interference
5. Phenotype mixing --> Phenotypic masking and pseudotypes possible |
|
|
Term
|
Definition
- Animal models
- Lesions in embryonated eggs
- Electron microscopy
- Tissue culture --> CPE, syncytia, inclusion bodies, hemadsorption, hemagglutionation, interference, transformation assays, end point dilution and plaque assays
- Immunological techniques --> Immunostaining, ELISA and radioimmune assay (RIA)
- Biochemical methods --> Detection of viral specific enzymes
- Molecular approaches --> Detection of viral nucleic acid and PCR |
|
|
Term
Types of Viral Infections |
|
Definition
- Abortive: Failed infection with no viral replication due to defective virus or a non-permissive cell
- Lytic: Results in cell death due to viral replication or immune cytolysis --> Inclusion bodies, syncytia and other cytopathic effects are evident
- Persistent: Infection without cell death --> Viruses released by budding (chronic), no viral gene expression (latent), or immortalization of cell by oncogenic viruses (transforming) |
|
|
Term
Steps in Viral Pathogenesis |
|
Definition
- Entry into the body
- Replication
- Incubation period and disease production
- Convalescence (recovery) |
|
|
Term
Entry of Viruses into Body |
|
Definition
- Can enter through skin breaks, mucosal surfaces, and conjunctiva
- Mucosal surfaces: Respiratory, GI and UG tracts
- Some viruses will remain local while others will immediately disseminate
- IgA and IgE and macrophages provide protection
- Mucous and ciliated epithelial cells in the nasal cavity provide protection
- Cool temperature of the URT inhibits viral replication in many viruses
- Entry via M cells in the GI tract
- Entry via direct inoculation into the conjunctiva |
|
|
Term
Primary Replication of Viruses |
|
Definition
- Occurs at the site of entry if cells are permissive
- Will travel if cells are not permissive
- Localized infections: Undergo primary replication and remain in the same area |
|
|
Term
Incubation Period of Viral Infections |
|
Definition
- Time between infection of the host and the onset of specific symptoms
- Includes prodrome but is not exclusive to prodrome
- Virus amplifies during this period
- Virus may spread to secondary sites
- Virus may cause disseminated or systemic infection |
|
|
Term
|
Definition
1. Local spread on epithelial surfaces
2. Subepithelial invasion and lymphatic spread
3. Spread through the blood stream --> Most effective mode
- May cause viremia either primarily or secondarily
- Virus may travel in the bloodstream freely or cell-associated
4. Spread through peripheral nerves
- Centripetal or centrifugal movement
- Lytic vs. noncytocidal life cycles |
|
|
Term
Methods of Viral Invasion of Target Tissues |
|
Definition
1. Invasion of the skin via the bloodstream --> Generalized rash
- Macule, papule, vesicle, pustule, and nodule forms possible
2. Invasion of the CNS --> Via bloodstream (hematogenous), meninges/CSF, or peripheral nerves
3. Invasion of other tissues --> Via bloodstream --> Can infect liver, glands and fetal tissue
- If virus infects glandular tissue then virus can be secreted and transmitted in body secretions |
|
|
Term
Viral Cell and Tissue Tropism |
|
Definition
- Depends entirely on receptors, transcription factors, and proteolytic enzymes
- Can only replicate in a permissive cell
- Needs to be able to use cell machinery, etc |
|
|
Term
Production of Disease by Viruses |
|
Definition
1. Directly kill the cells they infect
2. Impair the function of the cells they infect
3. Immune responses --> Innate and adaptive
- Cell-mediated immune response --> cytolysis, immune coplex deposition, antibody enhancement of viral infection, and cross-reactivity with other tissues
- Immune response can result in autoimmune sequelae |
|
|
Term
|
Definition
- Ability of the virus to cause illness or death of host
- Affects severity and susceptibility to disease
- Depends on both host and viral factors:
1. Route of exposure
2. Immune status, age, and general health
3. Viral dose
4. Genetics of the virus and the host
5. Ability of the host to repair the damage from virus |
|
|
Term
|
Definition
- Different for acute vs. chronic infections --> Doesn't occur completely in chronic infections
- Symptoms may continue throughout the recovery period --> Continued tissue repair
- Most of the time the host develops resistance to the same or similar strains to the infection |
|
|
Term
|
Definition
- Based on the fact that viruses are obligate intracellular parasites, composed of nucleic acid and protein, and elicit virus-specific immune responses
1. Cell culture: Requires infectious growth competent viruses but some viruses do not grow in culture and slow
2. Assays for virus-specific antigens/genomes
3. Detection Directly from Clinical Specimens --> Immunostaining, nucleic acid hybridization and nucleic acid amplification (PCR) --> Detects virus particles, proteins or nucleic acids
4. Serodiagnosis --> IgG and IgM detection from acute and convalescent serum samples |
|
|
Term
|
Definition
- Hemadsorption: Some viruses express a protein that binds to RBCs --> Virus infected cells bind RBCs
- Determined through a hemagglutination assay |
|
|
Term
|
Definition
- 2 + ssRNA viruses --> Diploid!!
- Can cause leukemias/sarcomas, wasting diseases, and immunosuppressive diseases
- Examples: HTLV-1, HTLV-2, HIV-1, HIV-2, and HFV
- HIV-1 --> Clades A-K |
|
|
Term
|
Definition
- Enveloped virus with matrix protein tightly associated with the envelope
- Surface receptor (gp120): Binds CD4
- Transmembrane (gp41): Extends across the envelope
- Nucleocapsid (p7): Binds tightly to genomic RNA
- Enzymes: Reverse transcriptase, protease, and integrase |
|
|
Term
|
Definition
- + strand --> Eukaryotic mRNA with 5' cap and 3' poly A tail
- Reverse transcriptase turns RNA to DNA
- 5' and 3' regions of the genomic material are regulatory and essential for incorporation in the genome and replication |
|
|
Term
|
Definition
- Tat: transcriptional transactivator --> Can be released from infected cells to initiate apoptosis in uninfected cells
- Nef: mebrane-associated --> Down regulates CD4 and MHCI expression --> Mechanism for non-progressors!!!
- Vpr: Virion-associated --> Causes apoptosis of infected cells and causes T-cells to arrest in G2 stage
- Vpu: Infulences virus release
- Vif: Facilitates virus spread by preventing deamination of viral DNA by the cellular proteins
- Rev: Post-transcriptional transactivator --> Essential for replication |
|
|
Term
|
Definition
- High levels of infection in CD4 T-cells and macrophages
- Low levels of infection in dendritic cells, Langerhan's cells, and plasmacytoid dendritic cells --> Enable dissemination |
|
|
Term
|
Definition
1. Receptor binding
2. Entry
3. Reverse transcription
4. Nuclear entry of DNA
5. Integration
6. RNA synthesis
7. Protein synthesis
8. Virion assembly
9. Virion release
10. Proteolytic maturation |
|
|
Term
|
Definition
- gp120 binds CD4
- Co-receptors: CCR5 and CXCR4
- CCR5 on both T-cells and macrophages
- CXCR4 on T-cells
- Certain strains preferentially use one co-receptor over the other --> M and T tropic strains
- CCR5 homozygous deletion --> Resistance to HIV-1
- Long-term non-progressors --> Elevated levels of MIP-1A, MIP-1B, and RANTES chemokines (competitively inhibit CCR5) |
|
|
Term
|
Definition
- Fusion of viral envelope and host cell lipid membrane
- Inhibition: T-20 --> Prevents fusion
- Maraviroc: Binds CCR5 receptor |
|
|
Term
HIV Reverse Transcription |
|
Definition
- ssRNA --> dsRNA
- Major target for anti-retroviral DNA --> Nucleoside and non-nucleoside reverse transcriptase inhibitors
- High misincorporation rate due to lack of proof reading function
- Accumulation of mutations and mutants |
|
|
Term
|
Definition
- Most retroviruses can only infect dividing cells
- T-cells are dividing cells so nuclear membrane breaks down frequently so it's easy
- Macrophages are non-dividing cells so DNA must have another mechanism to get into the nucleus
- CA protein facilitiates nuclear entry in macrophages |
|
|
Term
Integration of HIV DNA into Host Genome |
|
Definition
- Integrated via integrase
- Major target for treatment --> Raltegravir and elvitegravir
- Provirus: Integrated retroviral DNA
- Once incorporated, cannot remove from host genome
- Transmitted to daughter cells when cell replicates in the future |
|
|
Term
|
Definition
- Uses host RNA polymerase II
- Uses host mechanisms to complete this step
- RNA polymerase II also has no proof reading function
- High level of mutations possible at this step |
|
|
Term
|
Definition
- Structural and ezymatic proteins are synthesized as precursor proteins
- Large polypeptides are formed here |
|
|
Term
HIV Assembly, Release, and Maturation |
|
Definition
- Precursor proteins and unspliced mRNA are assembled and organized at the cell membrane
- Matrix protein helps organize at the membrane
- Capsid, genome and precursor proteins are packaged together into virions
- Released via budding
- Precursor proteins are proteolytically cleaved by the virally encoded protease --> Occurs extracellularly |
|
|
Term
|
Definition
- Drop in CD4 T-cell count with acute infection
- Viral load increases with acute infection
- Viral load will increase if left untreated
- CD4 T cell cound recovers initially but will steadily decline if left untreated
- AIDS: CD4 >200 cells/mL |
|
|
Term
|
Definition
- 10^8-10^9 HIV virions produced per day
- High rate of replication and high mutation rate leads to more pathogenic strains!!
- Evolution from non-syncytium producing strains to syncytium-inducing strains --> Higher pathogenicity |
|
|
Term
HIV Induced T-cell Abnormalities |
|
Definition
- Loss of response to recall antigens --> Memory response loss
- Impaired proliferation
- Impaired IL-2 receptor expression
- Altered cytokine production --> Shift from Th1 to Th2 profile
- Th1: Cell-mediated immunity
- Th2: Humoral immunity |
|
|
Term
HIV Induced Macrophage Abnormalities |
|
Definition
- Impaired chemotaxis
- Impaired phagocytosis
- Impaired cytokine production |
|
|
Term
|
Definition
1. Direct: High levels of virus can be cytotoxic
- Interferes with cellular gene expression
- Loss of membrane integrity through budding
- Accumulation of high levels of unintegrated viral DNA in the nucles
2. Syncytial Formation: T-cells fuce via CD4 and gp120 interaction
3. Immune Attack: CTL response and antibody dependent cell-mediated cytotoxicity (ADCC)
4. Apoptosis: Tat facilitates apoptosis |
|
|
Term
|
Definition
- Highest levels in Sub-Saharan Africa, India, China, and Russia
- 33 million people living with HIV
- 50,000 new cases in the US every year --> Highest rates in 15-24 year olds
- Estimated 230,000 undiagnosed patients in the US
- 75% male in the US
- HAART treatment has drastically changed the epidemiology and transmission
- HIV infections in the US are most common in minority populations
- Prevention, education, and treatment are difficult in resource poor countries |
|
|
Term
Acute HIV Infection Symptoms |
|
Definition
- Fever
- Rash
- Adenopathy
- Sore throat
- Mouth, esophageal, and genital ulcers
- Muscle/joint pain
- Diarrhea
- Nausea/vomiting
- Hepatosplenomegaly
- Oral thrush
- Weight loss
- Cognitive impairment and neurological findings |
|
|
Term
|
Definition
- Replication in peripheral blood compartment
- Replication in other compartments acting as reservoirs
- Replication in macrophages
- Presentation of antigens by dendritic cells
- Implications for the induction of resistance |
|
|
Term
|
Definition
- Rapid oral testing --> ELISA to detect circulating antibodies to HIV
- Western blot: Looks for antibodies in serum using strips prepared with HIV proteins
- Viral load test for suspicion of acute infection --> Seroconversion can take 8-12 weeks or longer
|
|
|
Term
|
Definition
- Prognosis prediction
- Predicts the risk of opportunistic infections
- Helps determine whether therapy should be initiated
- Used to follow response to therapy --> Want CD4 >500 cells/mL |
|
|
Term
|
Definition
- Detects free HIV RNA in plasma --> copies/mL
- Used to predict prognosis
- Good for acute infection diagnosis
- Helps determine when to initiate therapy
- Used to follow response to therapy |
|
|
Term
HIV and Opportunistic Infections/Neoplasms |
|
Definition
- Pneumocystic pneumonia (PCP)
- Tuberculosis (TB)
- Toxoplasmosis
- Oral thrush
- Hepatitis
- Cryptococcus
- Neoplasms: Kaposi's sarcoma and non-Hodgkin's lymphoma |
|
|
Term
|
Definition
- HAART therapy
- Initiation of therapy decreases viral load and increases CD4 count
- Decreases transmission to sexual partners
- Lowers risk of dying from other complications such as heart disease and liver disease
- Even if CD4 count is high --> Making a billion viruses a day is just not good for you...
- Really want to keep viral count low!! --> Undetectable |
|
|
Term
Nucleoside Reverse Transcriptase Inhibitors |
|
Definition
- Emtricitabine and Tenofovir
- Nucleoside analogs that stop the progression of RNA production --> Chain terminators
- 2 NRTIs used in combination with 1 NNRTI, 1 PI or 1II
- Side effects: Lactic acidosis with hepatic steatosis, hyperpigmentation of palms and soles (emtricitabine), GI symptoms and nephrotoxicity (Tenofovir)
- Drug interactions: Few
- Elimination: Renal excretion --> Dose adjustment |
|
|
Term
Non-Nucleoside Reverse Transcriptase Inhibitors |
|
Definition
- Efavirenz
- Bind to reverse transcriptase to change conformation and deactivate enzyme
- Side effects: CNS side effects, weird dreams, and drowsiness
- Drug interactions: P450 inducers, inhibitors or substrate |
|
|
Term
|
Definition
- Atazanavir
- Inhibit the HIV protease and inhibit the cleavage of the polyprotein precursors
- Side effects: GI disturbances, metabolic changes, glucose intolerance, increased transaminases and kidney stones
- Drug interactions: P450 substrate and inhibitor
- Often packaged with ritonavir --> Decreases metabolism by P450 --> Increased half-life |
|
|
Term
|
Definition
- Raltegravir
- Inhibits the integrase --> Inhibits HIV DNA integration into host genome
- Side Effects: GI upset, headache, elevated CPK
- Drug interaction: Low interaction
- Generally well tolerated and taken twice daily |
|
|
Term
Other HIV Medication Targets |
|
Definition
- Fusion inhibitors: Enfuvirtide (T-20) --> Inhibits gp41
- CCR5 Co-receptor Anatagonist: Maraviroc --> P450 substrate --> Drug interactions!! |
|
|
Term
|
Definition
- Combination therapy of 3 drugs
- Always 2 NRTIs with 1NNRTI, PI or II --> Daily dosing now
- Ex. Tenofovir/emtricitabine/efavirenz (Atripla)
- Combination to reduce resistance and to get viral load down to undetectable levels
- Benefits of therapy: Reduced transmission rate, prevalence of neoplasms and opportunistic infections, decreased resistance of virus strains, and delay of disease progression
- Risks: Decreased quality of life due to side effects, inconvenience of having to take meds, possibility of development of drug resistance and transmission of drug resistant virus, and unknown long-term toxicity |
|
|
Term
|
Definition
- Change in body composition --> Wasting and altered fat deposition
- Atherosclerosis
- Internal abdominal fat deposition |
|
|
Term
|
Definition
- Variola virus
- Causes severe generalized disease
- Vaccination from 1967-1979
- Vaccination: Inoculation with cowpox virus
- First virus eradicated by immunization |
|
|
Term
|
Definition
- Orthopoxviruses --> Variola, monkeypox, vaccinia, and cowpox viruses
- Yatapoxviruses --> Tanapoxvirus and yabapoxvirus
- Parapoxviruses --> Orf and pseudocowpox viruses
- Molluscipoxviruses --> Molluscum contagiosum virus
- Characteristics: Huge and tough even though they are enveloped
- Brick/ovoid capside shape (complex)
- Envelope not obtained from membrane and not required for infectivity
- Genome: ds DNA --> 150-300 proteins |
|
|
Term
|
Definition
- Surface tubules on outside
- Envelope
- Outer membrane
- Lateral body ~ tegument
- Core membrane
- Core: Viral DNA and protein |
|
|
Term
Replication of Poxviruses |
|
Definition
- Core released into cytoplasm after loss of outer membrane
- Early transcription --> Using viral DNA dependent RNA polymerase
- Early mRNA --> enzymes and virion proteins
- DNA replication by viral DNA polymerase
- Late transcription by viral polymerase --> Structural
- Assembly and release of virions by budding or cell lysis |
|
|
Term
Pathogenesis and Immunity of Poxviruses |
|
Definition
- Infection requires close contact with droplets or fomites
- Primary symptoms: URT infection with brief viremia and spread to secondary organs
- Recovery generally occurs with virus elimination
- Survival results in life-long immunity
- Small pox causes disseminated disease while others generally cause localized infections
- Virulence: Mechanisms for evading host cell immune responses
- Immune response: Cell-mediated and humoral immunity are crucial |
|
|
Term
Clinical Symptoms of Smallpox |
|
Definition
- Day 4: Asymptomatic viremia
- Day 8: 1st signs of fever
- Days 12-14: Rise in fever, severe aching pains and prostration
- Days 16-18: Appearance of papular rash --> Begins on face and spreads to exteremities
- Rash: Papular --> Vesicular --> Pustular --> Crusty
- Synchronous rash |
|
|
Term
Mechanisms Allowing Eradication of Smallpox |
|
Definition
- Infects only humans
- Single stable serotype
- Safe and effective vaccines are available --> From animal poxviruses
- Consistent and distinct disease presentation --> Easy to diagnose
- Stable, cheap and easy-to administer vaccine
- Vaccination indicated by scar
- WHO program promoted vaccination worldwide
- Can also vaccinate after exposure to prevent or ameliorate severity of disease |
|
|
Term
Complications with the Smallpox Vaccine |
|
Definition
- More deaths than any other approved vaccine
- 150-1,000 people will die in the US
- Adverse cardiac effects
- Accidental injection into the eye --> Keratoconjunctivitis
- Generalized vaccinia
- Eczema vaccinatum
- Vaccinium necrosum |
|
|
Term
Molluscum Contagiosum Virus |
|
Definition
- Worldwide --> Human only virus
- Transmission: Direct contact or fomites
- Presentation: Self-limiting lesions --> Pearly-white and painless --> NOT palms and soles
- May take months --> years to resolve
- Children and immunocompromised are susceptible |
|
|
Term
|
Definition
- Characteristic skin lesions and rash
- Smallpox: Detection of viral antigens and growth in cell culture/embryos
- Molluscum contagiosum: Characteristic lesions and histological detection |
|
|
Term
Treatment and Prevention of Poxviruses |
|
Definition
- Treatment: Smallpox vaccine, vaccinia-imune human globulin (VIG), and no antiviral treatment for molluscum contagiosum
- Can surgically remove lesions due to molluscum contagiosum
- Prevention: Vaccine and decontamination with standard disinfectants, hot water, and bleach |
|
|
Term
|
Definition
- Similar to smallpox
- Monkey reservoir
- Found in tropical rain forests and West and Central Africa
- Transmission: Direct contact
- 1st outbreak in the US in June, 2003 |
|
|
Term
|
Definition
- Reservoir: Sheep and goats
- Transmission: Direct contact
- Presentation: Lesion at site of abrasion
- Usually self-resolving
- Results in immunity |
|
|
Term
Structure of Herpes Viruses |
|
Definition
- Envelope composed of viral glycoproteins and cellular membrane
- Icosahedral capsid: Contains ds DNA genome
- No viral polymerase
- Tegument containing proteins |
|
|
Term
|
Definition
- Herpes Simplex Virus 1 (HSV-1) --> Oral Herpes
- Herpes Simplex Virus 2 (HSV-2) --> Genital Herpes
- Varicella Zoster Virus (VZV) --> Chicken pox/shingles
- Epstein-Barr Virus (EBV) --> Mononucleosis
- Kaposi's Sarcoma Herpes Virus (KSHV) --> Kaposi's Sarcoma, aka HHV-8
- Cytomegalovirus (CMV) --> Mononucleosis
- Human Herpes Virus 6 (HHV-6) --> Roseola |
|
|
Term
|
Definition
- Tranmission: Saliva or sexual contact --> Both transmitted when patient is asymptomatic
- > 80% of US population is infected with HSV-1 and ~20% over the age of 14 are infected with HSV-2
- Acute and chronic infections
- Primary infection: Often asymptomatic
- Reactivation --> Cold sores or genital lesions |
|
|
Term
Disseminated Symptoms of Herpes Simplex Viruses |
|
Definition
- Both HSV-1 and HSV-2 develop latency by traveling through peripheral nerves to ganglia (trigeminal and sacral)
1. HSV-1: Encephalitis, keratoconjunctivitis, oral symptoms, pharyngitis, esophagitis, tracheobronchitis, gladiatorum, genital lesions and finger lesions (whitlow)
2. HSV-2: Encephalitis, oral symptoms, pharyngitis, genital lesions, perianal lesions, and whitlow
- HSV-2 can also cause neonatal systemic infections
- Pregnant women are screened for HSV-2 and advised to have a C-section if positive |
|
|
Term
Diagnosis, Treatment and Prevention of Herpes Simplex Viruses |
|
Definition
- Diagnosis: Tzanck smear looking for CPE, serology, and PCR
- Treatment: Abreva (HSV-1), valacyclovir, and acyclovir
- Prevention: Normal disinfectants, avoid exposure to HSV + patients, and use protection during sex |
|
|
Term
|
Definition
- Acute infection: Chicken pox
- Latent/reactivation infection: Shingles or post-herpetic neuralgia
- Vaccine: Live-attenuated vaccine to prevent both chicken pox and shingles
- Extremely contagious --> >90% attack rate
- Transmission: Respiratory droplets and direct contact with skin lesions |
|
|
Term
VZV Infection Risk Groups |
|
Definition
- Unvaccinated children ages 5-9 --> Mild disease
- Unvaccinated teens and adults --> More severe disease
- Immunocompromised patients and newborns
- Previously infected elderly patients --> Shingles or post-herpetic neuralgia |
|
|
Term
Pathogenesis of Varicella Zoster |
|
Definition
- Droplets --> Respiratory tract infection
- Travels to lymphatics --> Liver, spleen and reticuloendothelial system
- Primary viremia when virus travels from lymphatics
- Secondary viremia shows symptoms of headache, malaise, and fever
- Virus travels to mucous membranes and skin
- Virus then develops latency by traveling through peripheral nerves and hiding in ganglia |
|
|
Term
Varicella Zoster Latency and Reactivation |
|
Definition
- 10-20% of infected patients will develop shingles
- Post-herpetic neuralgia occurs less frequently and lasts longer
- Shingles --> May last a couple weeks and painful
- Post-herpetic neuralgia --> May last months and very painful
- Keratitis also possible |
|
|
Term
Immune Response to Varicella Zoster Virus |
|
Definition
- Cell-mediated: Required to clear virus
- Antibodies: Limit viremia
- Immunity: Life-long develops against reinfection of varicella
- Virus still remains latent so virus never truly cleared completely |
|
|
Term
Clinical Manifestations of Varicella Zoster Virus |
|
Definition
- Incubation: 14-21 days
- Prodrome: Fever and malaise
- Rash: Appears in crops (Papules --> Vesicles --> Pustules --> crusts)
- Non-synchronous rash
- Complications: Secondary bacterial infections, pneumonia, encephalitis, hepatitis, severe rash and possibly Reye's syndrome |
|
|
Term
Diagnosis, Treatment and Prevention of Varicella Zoster Virus |
|
Definition
- Diagnosis: Clinical presentation, Tzanck smear, detection of viral antigens, PCR, and rise in antibody titer
- Treatment: None for mild cases, acyclovir for chickenpox, famciclovir or valacyclovir for shingles, and new shingles vaccine
- Prevention: vaccination with live-attenuated vaccine to elicit humoral and CMI responses --> Immunity may not be life long
- Vaccine is NOT safe for immunocompromised and pregnant patients |
|
|
Term
|
Definition
- Normal herpes virus structure and replication cycle
- Widespread and transmitted by saliva
- Primary replication: Oropharynx, viremia, and latency in B-cells
- Presentation: Asymptomatic in young children (2-3 years) or mononucleosis in older people
- Pathogenesis: Atypical lymphocytes/Downey cells and heterophile antibodies are produced |
|
|
Term
Rare Complications from Epstein-Barr Virus |
|
Definition
1. Oral Hairy Leukoplakia: Epithelial cell proliferation --> Looks like oral thrush
2. Burkitt's Lymphoma: Lymphoma of the jaw and face
3. Nasopharyngeal carcinoma: Primarily in Asian adult men
4. Hodkin Lymphoma: B-cell cancer |
|
|
Term
Diagnosis of Epstein-Barr Virus |
|
Definition
- Presence of atypical lymphocytes/Downey cells in blood smear
- Monospot Test: Looks for heterophile antibodies |
|
|
Term
|
Definition
- Herpes virus structure and replication
- Most people are infected without knowing it
- Tranmission: Transplacental, during delivery, breast milk, saliva, sexual contact and blood transfusions
- Productive and latent infections are possible --> Infect different cell types
- Virus can be shed in urine and vaginal secretions
- Immune response: Cell-mediated immunity |
|
|
Term
Clinical Manifestation of Cytomegalovirus |
|
Definition
- Primary infection --> Usually asymptomatic but mononucleosis possible
- Serious disease: Fetus if the mother is seronegative and gets infected during pregnancy --> Congenital defects
- "Blueberry Muffin Baby"
- Reactivation in immunocompromised patients --> Pneumonia, hepatitis, diarrhea and retinitis possible |
|
|
Term
Diagnosis, Treatment and Prevention of Cytomegalovirus |
|
Definition
- Diagnosis: Observation of "Owl's Eye" on blood smear --> Nuclear inclusion body
- Treatment: Gancyclovir for serious illness and CMV immune globulin injection
- Prevention: No vaccine, isolation of CMV-infected infants to limit spread and screening of blood and organs |
|
|
Term
Human Herpes Virus 6 (HHV-6) |
|
Definition
- Causes roseola --> Common rash in children
- Transmission: Oral secretions
- Virus replicates in salivary glands --> Lipophilic
- Presentation: High fever then non-descript rash
- Usually short disease course --> ~24 hours |
|
|
Term
Kaposi's Sarcoma Herpes Virus (KSHV) |
|
Definition
- HHV-8
- Most common in older men of Mediterranean decent
- Opportunistic infection --> Infects patients with low T-cell count
- Causes Kaposi's sarcoma |
|
|
Term
|
Definition
- Three main groups
1. Virucides: Directly inactivates virus before cell infection
2. Antivirals: Inhibits viral replication
3. Immunomodulators: Alters the host immune response |
|
|
Term
Antiviral Therapy of Influenza Virus |
|
Definition
- Influenza: - strand RNA virus --> Hemagglutinin and Neuraminidase surface proteins
1. Amantidine: Adamantanes --> Binds M2 protein to prevent viral uncoating --> Lots of resistance now!
2. Oseltamivir (Tamiflu): Neuraminidase inhibitor --> Competitively inhibits neuraminidase --> Little resistance
- Side effects: Nausea, vomitting, and transient neuro effects
- Absorption: Oral, oral inhaler, or IV for emergencies
- Elimination: Renally --> Dose adjustment necessary
- Used for treatment and prophylaxis |
|
|
Term
Hepatitis C Virus Treatment |
|
Definition
- Hep C: + strand RNA virus --> No vaccine
- Begins acute but 80% develop chronic disease
1. Interferons --> Immunomodulators that increase phagocytosis and cytotoxicity of immune cells
2. Ribavirin --> Guanosine analog --> Mutagenesis and immunomodulatory effects
3. Telaprevir --> Protease Inhibitors --> Directly inhibits HCV protease for genotype 1 infections
- Combination therapy --> Improves results |
|
|
Term
|
Definition
- Immunomodulators
- Use: Hepatitis B and C infections
- Mechanism: Transmembrane signaling --> Enhances phagocytic and cytotoxic effects of leukocytes
- Side Effects: Flu-like symptoms, neuropsychiatric symptoms, bone marrow suppression and injection site reactions
- Pegylation: Addition of polyethylene glycol (PEG) --> Reduces renal clearance to increase half-life |
|
|
Term
|
Definition
- Causes viral mutagenesis and immune modulation
- Uses: Hepatitis B and C infections and Respiratory Syncytial Virus (RSV)
- Side Effects: Hemolytic anemia, insomnia, and teratogenic
- Elimination: Renal --> Adjust dosing
- Teratogenicity can occur if either the mother or the father takes the medication --> Transmitted through sperm and eggs |
|
|
Term
|
Definition
- Directly inhibits NS3-NS4a Protease
- Catalyzes cleavage of non-functional viral polyproteins to active proteins
- Reduces the host innate immune response to HCV
- Side effects: Nausea, vomitting, rash, and bone marrow suppresion
- Drug interactions: P450 substrate and competitive inhibitor |
|
|
Term
Treatment of Herpes Virus |
|
Definition
1. Acyclovir --> Nucleoside analog --> Resistance emerging
2. Cidofovir --> Nucleoside analog --> Good for acyclovir resistant strains (TK resistance)
3. Foscarnet: Non-competitive inhibitor of viral DNA polymerase
4. Valacyclovir: Prodrug of acyclovir --> Better absorption and can be taken less frequently |
|
|
Term
|
Definition
- Antiviral nucleoside analog
- Needs to be activated by viral threonine kinase and then tri-phosphorylated to be added to DNA chain
- Side Effects: Nausea, vomitting and headache
- Renal toxicity and neuro symptoms possible
- Drug interactions: Other nephrotoxic agents |
|
|
Term
|
Definition
- Non-enveloped --> Tough virion
- Icosahedral capsid surrounding dsDNA genome
- Many subgroups with multiple serotypes --> Different diseases
- Causes 5-10% of civilian respiratory disease --> Higher outbreaks in the military and on college campuses |
|
|
Term
|
Definition
- Cell binding proteins extend from the 12 vertices of the capsid
- Virus enters cell via endocytosis
- Replicates in nucleus using viral DNA polymerase
- Early and late mRNA and protein synthesis
- Assembly and accumulation of particles in the nucleus --> Inclusion bodies
- Released through cell lysis |
|
|
Term
Transmission of Adenoviruses |
|
Definition
- Aerosolized droplets --> Major route
- Fecal-oral
- Fomites --> Non-enveloped so tough
- Direct inoculation of the conjunctiva --> From swimming pools, opthalmic instruments, fingers, and medications |
|
|
Term
Pathogenesis of Adenoviruses |
|
Definition
- Disease presentation depends on the tissue the virus infects
1. Primary replication: Mucoepithelium of conjunctiva, respiratory tract or GI tract
2. Viremia and dissemination occurs
3. Secondary targets --> Kidney, bladder, liver, lymphoid tissue and CNS
- Most infections are asymptomatic
- Virus can be shed intermittently from pharynx and in feces
- Lytic Infection: Directly kills permissive cells
- Persistent infection --> In non-permissive cells of lymphoid tissues --> May reactivate later |
|
|
Term
Immune Response to Adenoviruses |
|
Definition
- Serotype-specific --> Both humoral and CMI responses are important
- Produces life-long IgG antibodies
- Maternal IgA antibodies protect infant
- Viral proteins help it evade the host immune system |
|
|
Term
Clinical Presentation of Adenoviruses |
|
Definition
- Acute febrile pharyngitis --> Cough, stuffy nose, and inflamed pharynx in young children (<3 years)
- Pharyngoconjunctival fever --> Older children
- Acute respiratory disease (ARD) --> Usually in the winter, occurs in outbreaks, usually in the military or in college --> Most severe
- Other respiratory diseases --> Colds, laryngitis, croup, and pneumonia
- "Swimming pool" conjunctivitis
- Gastroenteritis and diarrhea --> Usually hospital acquired |
|
|
Term
Diagnosis, Treatment and Prevention of Adenoviruses |
|
Definition
- Diagnosis: Viral cultures looking for CPE, direct antibody detection, and serotyping or genotyping
- Treatment: Supportive for symptoms
- Prevention: Good hygiene and isolation of infected patients
- Vaccines: None available currently, lots of serotypes and might interfere with future gene therapy vectors |
|
|
Term
|
Definition
- Erythroviruses --> Infects erthyroid progenitor cells
- B19 is the only important human pathogen
- Small, non-enveloped with icosahedral capsid
- ssDNA molecules --> Negative-sense
- Ubiquitous --> Nearly 90% of adults are IgG positive
- Transmission: Close contact, fomites and respiratory droplets |
|
|
Term
|
Definition
1. Binds mitotically active erythroid progenitor cells
2. Enters via coated pits
3. Replication, transcription, and assembly in nucleus
4. Requires host transcription factors and DNA polymerase
5. Released via cell lysis |
|
|
Term
Clinical Manifestation of Parvoviruses |
|
Definition
1. Fifth disease --> Erythema infectiosum --> 1 of 5 of the common childhood rashes
- Acute, benign and very contagious
- Begins on face and spreads to trunk and limbs
- May be preceded by fever, malaise and itching
2. Hydrops fetalis --> When mother becomes seropositive during pregnancy
3. Aplastic crises --> Triggers crises in sickle cell patients |
|
|
Term
Diagnosis, Treatment and Prevention of Parvoviruses |
|
Definition
- Diagnosis: Detection of viral DNA in serum or tissue and B19-specific IgM and IgG
- No treatment or prevention |
|
|
Term
|
Definition
- Non-enveloped viruses with icosahedral capsid --> Over 100 genotypes, 16 groups
- Small dsDNA genome
- Can be oncogenic
- Very contagious --> Can be shed even without lesion or symptoms
- Transmission: Direct contact through fomites, sexual contact, birth, and asymptomatic shedding |
|
|
Term
Replication of Human Papillomaviruses |
|
Definition
1. Enters via skin breaks
2. Infects epithelial cells --> Basal keratinocytes
3. E gene expression within virus stimulates cell division
4. Virus replications in host nucleus
5. Stimulates basal keratinocytes to differentiate into spinosum
6. Viral transcription and protein synthesis occurs
7. Virion assembly in granulosum layer
8. Released in dead keratinocyte layer |
|
|
Term
Clinical Manifestations of HPV |
|
Definition
1. Benign, common skin plantar warts --> Flat warts caused by HPV-1,2,3,4
- Infection remains local and typically regresses in months to years --> Frequent recurrence
- Most common in children or adolescents
2. Head and Neck Squamous Cell Carcinomas --> Invasive tumors in oropharynx and oral cavity caused by HPV-16
- Can be benign or malignant
- Risk factors: Smoking, alcohol use, poor oral hygiene, and history of oral cancer
3. Anogenital warts --> Caused by HPV-6 and HPV-11
- Condylomata acuminata --> Benign warts
- Laryngeal papillomas also possible
4. Cervical cancer --> Caused by HPV-16 and HPV-18
- Very common STD
- 85% of cancers contain integrated HPV DNA --> Inactivates E1 and E2 and blocks viral replication but promotes persistence
- E6 and E7 viral proteins are oncogenes --> Inactivate p53 |
|
|
Term
Diagnosis, Treatment and Prevention of HPV |
|
Definition
- Diagnosis: Visual inspection and histology, presence of koilocytotic cells, and PCR
- Treatment: Surgical or chemical removal of warts and stimulation of immune response
- Prevention: Avoid direct contact, use barriers during sex, and vaccinate
- Vaccine: Gardasil (Quadrivalent HPV-6,11,16, and 18) with virus-like particles (capsid without genome) |
|
|
Term
|
Definition
- JC and BK viruses --> Ubiquitous but usually asymptomatic unless immunocompromised
- Non-enveloped icosahedral capsid --> small dsDNA genome
- Transmission: Respiratory droplets |
|
|
Term
Pathogenesis of Human Polyomaviruses |
|
Definition
- Narrow host and cell type range --> Infect lymphocytes and then disseminate
- BK virus: Establishes latent infection in the kidneys
- JC virus: Establishes latent infection in the kidneys, B-cells and monocyte-lineage cells
- Viral replication is blocked in immunocompetent individuals
- Reactivation --> Viral shedding in urine and respiratory secretions
- BK reactivation --> Severe UTIs
- JC reactivitation --> CNS infection/progressive multifocal leukoencephalopathy (PML) |
|
|
Term
Treatment and Prevention of Polyomaviruses |
|
Definition
- No diagnosis, treatment or prevention
- Prevent reactivation by treating for the immunosuppression --> Increase T-cell count |
|
|
Term
|
Definition
- Most are enteroviruses --> Poliovirus, coxsackie-viruses A + B, echoviruses, and non-polio enteroviruses
- Hepatitis A virus, rhinoviruses, and parechovirsues are also possible
- Tranmission: Mostly via the fecal-oral route but some have respiratory transmission
- Small + sense ssRNA virus with cell binding proteins within a canyon --> surface receptors must extend into canyon --> Hard for antibodies and medications to get in
- Icosahedral capsid structure |
|
|
Term
Replication of Picornaviruses |
|
Definition
1. Virus binds cell receptor
2. Genome is uncoated and delivered to cytoplasm --> Unknown mechanism
3. ssRNA genome directly translated into proteins
4. Viral polypeptide cleaved --> Viral RNA poly produced
5. Viral RNA poly synthesizes - sense and new + sense strands
6. Viral proteins are made
7. Viruses assembled in cytoplasm
8. Release by cell lysis |
|
|
Term
Epidemiology of Enteroviruses |
|
Definition
- Fecal-oral transmission but coxsackieviruses and echoviruses transmitted by aerosol droplets too
- Contaminated shellfish and water supply also possible
- Infection: Often asymptomatic but viral shedding can occur
- Outbreaks: Schools and daycares usually in the summer
- Poliomyelitis --> Worldwide eradication target
- Disease presentation: Depends on virus type and specific host |
|
|
Term
Clinical Manifestations of Picornaviruses |
|
Definition
- Poliovirus --> Poliomyelitis
- Coxsackie-viruses A + B --> Aseptic meningitis, carditis, and hand-foot-and-mouth disease
- Echoviruses --> Meningitis, etc
- Hepatitis A --> Hepatitis
- Rhinovirus --> Common cold
- Non-polio enteroviruses and parechoviruses --> Various diseases |
|
|
Term
Pathogenesis and Immunity of Enteroviruses |
|
Definition
- Disease determined by tissue tropism
- Sites of entry --> URT, oropharynx and GI tract
- Primary replication site --> Mucosa and lymphoid tissue of tonsils and GI tract
- Primary viremia --> Secondary target spread
- Infections often asymptomatic
- Viral proliferation and shedding may last 30 days or longer --> Even if antibodies are formed!!!
- Neutralizing antibodies produced --> IgA and IgG |
|
|
Term
Clincal Manifestation of Poliovirus |
|
Definition
- Asymptomatic in 90% of people
- Abortive poliomyelitis in 5% of people --> Minor illness which usually recovers
- Nonparalytic poliomyelitis in 1-2% --> Aseptic meningitis
- Paralytic poliomyelitis in 0.1-0.2% --> Most severe, can result in bulbar poliomyelitis resulting in respiratory paralysis
- Presentation: paralysis progresses over the first few days then recovers completely, results in residual paralysis or results in death |
|
|
Term
Diagnosis, Treatment and Prevention of Poliovirus |
|
Definition
- Diagnosis: Isolation of virus from throat, stool or CSF samples or rise in specific IgG/IgM antibodies
- Treatment: No standard antiviral therapy but pleconaril available, symptom relief, respiratory support and physical therapy
- Prevention: Vaccine (live-attenuated or inactivated viruses)
- Live-attenuated viruses replicate in the GI tract, induces IgA and provides longer duration of immunity
- Passive immunization with IVIG can protect unimmunized patients who have been exposed |
|
|
Term
|
Definition
- Main cause of aseptic/viral meningitis
- Presentation: non-specific URT disease, fever, rashes, aseptic meningitis, mild paresis, transient paralysis, etc
- Group A: Targets skin and mucous membranes leading to herpangina and hand-foot-and-mouth disease specifically
- Group B: Pleurodynia, myocarditis, and pericarditis |
|
|
Term
Diagnosis, Treatment and Prevention of Coxsackieviruses |
|
Definition
- Diagnosis: Isolation of virus in cell culture then immunoflourescence, ELISA and RT-PCR
- Treatment and prevention: No antiviral therapy or vaccine |
|
|
Term
|
Definition
- Enteric cytopathic human orphan viruses
- Presentation: Aseptic meningitis, URT infection, febrile illness with or without rash, infantile diarrhea, and hemorrhagic conjunctivitis
- Over 30 serotypes exist
- Transmission: Ingestion and inhalation of respiratory droplets
- Diagnosis: No typically done
- Treatment and prevention: None |
|
|
Term
|
Definition
- Main cause of the common cold
- More than 100 serotypes
- Replicates better at 33C than 37C --> Great for URT
- Deactivated by low pH present in GI tract
- Transmission: Direct contact, respiratory droplets, and indirectly via fomites
- Diagnosis: Test not typically done
- Treatment and prevention: No antivirals or vaccines but avoid contact with sick individuals |
|
|
Term
Pathogenesis of Rhinoviruses |
|
Definition
1. Virus infects cells in the nose, throat and URT
2. Symptoms indistinguishable from those caused by many other respiratory pathogens
3. Immunity is largely ineffective and transient --> Lots of serotypes
4. Nasal secretory IgA and serum IgG are induced but don't last very long |
|
|
Term
|
Definition
- Measles and Mumps in paramyxovirinae subfamily
- Pneumovirinae subfamily --> Pneumovirus (RSV) etc
- - sense ssRNA genome surrounded by helical nucleocapsid
- Virion contains viral RNA dependent RNA poly. |
|
|
Term
Replication of Paramyxoviruses |
|
Definition
1. Virus binds to cell receptor
2. Fusion protein fuses capsid and membrane --> Genome enters cytoplasm
3. Replication in cytoplasm
4. Viral RNA poly transcribes + sense RNA --> mRNA and template for new - sense RNA
5. Assembly of nucleocapsids in the cytoplasm
6. Genome inserted into nucleocapsid through pore
7. Released by budding |
|
|
Term
Five Classic Childhood Exanthems |
|
Definition
- Roseola (HHV-6)
- Fifth Disease (Parvovirus B19)
- Chicken pox (VZV)
- Measles (Rubeola)
- Rubella (German Measles) |
|
|
Term
|
Definition
- - sense ssRNA viruses with helical capsid
- Worldwide with winter and spring peaks
- Primarily in children
- Humans are natural host
- Transmission: respiratory droplets --> Very contagious!!
- Severity disease depends on host immune status and age
- Presentation: Cough, coryza, conjunctiva and photophobia --> With diffuse rash
- Koplik's spots in the mouth are diagnostic of Measles!! |
|
|
Term
|
Definition
- Inoculation of respiratory tract --> 7-10 day incubation
- Local replication in respiratory tract
- Spread via lymphatics --> Primary viremia
- Wide dissemination to conjunctiva, respiratory tract, urinary tract, small blood vessels, lymphatic system, and CNS
- Secondary viremia due to infected endothelial cells and T-cells
- Rash develops due to immune response |
|
|
Term
Clinical Outcomes of Measles |
|
Definition
- Postinfectious encephalitis
- Subacute sclerosing panencephalitis --> CNS sequelae
- No resolution of acute infection --> Defective CMI
- Pneumonia
- Atypical measles
- Recovery with life-long immunity |
|
|
Term
Diagnosis, Treatment and Prevention of Measles |
|
Definition
- Diagnosis: Hemagglutination/hemabsorption assay and syncytium formation (CPE)
- Treatment: No antivirals
- Prevention: Vaccine and isolation of infected patients
- Vaccine: Live-attenuated vaccine (since 1963) --> Given at 15 months and again between age 4-6 |
|
|
Term
|
Definition
- Paramyxovirus --> - sense ssRNA with helical capsid and viral RNA poly.
- Replication and epidemiology --> Similar to measles
- Transmission: Respiratory droplets and person-to-person
- Very contagious!!
- Primary infection site: Parotid gland (one or both)
- Secondary infection site: Testes, ovaries, peripheral nerves, eye, inner ear, CNS and pancreas (type I diabetes) |
|
|
Term
Clinical Manifestations of Mumps |
|
Definition
- Often asymptomatic
- Prodrome (fever, malaise) --> Sudden onset of tender swelling of parotid glands
- Other glands may also be infected
- Meningitis also possible (CNS infection)
- Incubation: 14-16 days |
|
|
Term
Diagnosis, Treatment and Prevention of Mumps |
|
Definition
- Diagnosis: Clinically, virus detection from saliva, CSF or urine by immunofluorescence and CPE, or rise in antibody titer
- Treatment: No antivirals
- Prevention: Vaccine and isolation of infected patients
- Vaccine: Live-attenuated vaccine in MMR vaccine |
|
|
Term
|
Definition
- Togavirus --> Other viruses are all zoonotic pathogens
- Presentation: Rubella and congenital rubella syndrome (tetrad)
- Enveloped + strand ssRNA with icosahedral nucleocapsid
- Transmission: Respiratory droplets and transplacentally
- Virus is shed during prodrome and after the onset of rash |
|
|
Term
Replication of Rubella Virus |
|
Definition
1. Binds cell receptor and enters cell via coated pits
2. Vesicle fuses with endosome --> Fusion protein allows for escape out of endosome
3. Nucleocapsid released into cytoplasm
4. Replication occurs in cytoplasm
5. Direct translation of ssRNA genome into polyprotein
6. Viral proteins are synthesized
7. Nucleocapsid is assembled in cytoplasm
8. Released by budding |
|
|
Term
|
Definition
- Occurs worldwide --> 10-20% of women of childbearing age are susceptible
- Primarily a childhood disease
- Humans are natural host
- Only one serotype --> Vaccination possible |
|
|
Term
|
Definition
- Incubation: 2-3 weeks
- Primary replication: Nasopharynx and local lymph nodes
- Primary viremia
- Secondary replication: Organs and skin (rash)
- Mild rash due to immune complexes --> Small erythematous macules (flat) on trunk and extremities
- Immune response: CMI for clearance and antibodies to reduce spread
- Life-long immunity results |
|
|
Term
Congenital Rubella Syndrome |
|
Definition
- Occurs if woman becomes seropositive during pregnancy
- Damage to fetus is worst if during the first 10-20 weeks of pregnancy
- Tetrad: Blindness, deafness, cardiac abnormalities, and mental retardation
- Can also cause "blueberry muffin baby" or be teratogenic
- Surviving infants are important reservoirs for perpetuating the virus for 30 months |
|
|
Term
Diagnosis, Treatment and Prevention of Rubella |
|
Definition
- Diagnosis: Difficult to isolate, no significant CPE, detection by heterologous interference, and serology
- Treatment: No antivirals
- Prevention: Live-attenuated vaccine --> Elicits respiratory IgA |
|
|
Term
Disease Due to Fungal Infections |
|
Definition
- Fungal toxins --> Amanita phalloides mushroom
- Fungal allergens --> Trigger symptoms of asthma, rhinitis, and sinusitis
- Fungal invasion and colonization |
|
|
Term
Cellular Structure of Fungi |
|
Definition
- Eukaryotic cells
- Cell wall containing chitin, glucans, and mannan
- Present as yeast, mold or dimorphic
- Yeast: Reproduces mostly by budding but a few by binary fission --> Produces pseudohyphae
- Mold: Produces septate or aseptate hyphae |
|
|
Term
Fungal Histopathology & Culture |
|
Definition
- Gram stain: Usually not useful, either don't stain or stain G+
- KOH: Outlines fungal cell walls because they resist hot alkali
- India ink: Negatively stains the capsule of Cryptococcus neoformans
- Silver and PAS Stains: Primary stain for fungi
- Culture: Needs special media (Sabouraud agar) to inhibit bacterial growth |
|
|
Term
|
Definition
- Superificial mycoses
- Molds that invade keratinized tissue (nails and skin)
- Can be transferred from animals to humans (zoophilic), soil to humans (geophilic), or human to human (anthropophilic) |
|
|
Term
Clinical Manifestations of Dermatophytosis |
|
Definition
- Tinea pedis: Athlete's foot
- Tinea cruris: Jock itch
- Tinea barbae: Beard
- Tinea corporis: Body fungus --> Ringworm
- Onychomycosis: Nail fungus
- Tinea capitus: Scalp fungus --> Alopecia
- Tinea versicolor --> Hyper or hypopigmentation of the skin
- Seborrheic dermatitis --> Dandruff
- Mycetoma: Madura foot --> Can lead to necrotic tissue requiring amputation |
|
|
Term
Diagnosis and Treatment of Dermatophytosis |
|
Definition
- Diagnosis: Clinical presentation, KOH prep, Wood's lamp, and by culture (slow)
- Treatment: Topical antifungals --> Head and shoulders contains zinc |
|
|
Term
|
Definition
- Usually affects patients with immune deficiencies
- Need to know the immune status of the patient to understand which infections they are more at risk for
- Candidiasis is most common |
|
|
Term
|
Definition
- Caused by Candida spp. --> C. albicans most common
- Yeast --> Produces pseudohyphae and hyphae in tissue
- Common colinization of the mouth but infection occurs when immune system becomes deficient |
|
|
Term
Clinical Manifestation of Candidiasis |
|
Definition
- Mucocutaneous: Occurs in patients with deficient T-cell mediated immunity, diabetes patients, and patients on broad spectrum antibiotics
- Disseminated: Patients with neutropenia, IV catheters and post-surgery (especially GI) |
|
|
Term
Mucocutaneous Candidiasis |
|
Definition
- Oral thrush/candidiasis: White patches on the lips and gums --> Usually the first presentation of HIV infection
- Vaginal, perianal and penile candidiasis are also possible
- Vaginal candidiasis occurs in immunocompetent patients
- Candida esophagitis: Can progress from oral thrush if left untreated --> Dysphagia and difficulty eating |
|
|
Term
|
Definition
- Entry: GI tract or IV catheters
- Diagnosis: Can be difficult because blood cultures are positive less than 50%
- Must examine patients for endophthalmitis/skin lesions |
|
|
Term
|
Definition
- Caused by Cryptococcus neoformans and gattii
- Only medically important capsulated fungus
- Capsule circulates in the blood and CSF --> Diagnosis
- Found in soil and bird droppings
- Primarily affects immunocompromised patients (HIV and transplant) |
|
|
Term
Clinical Manifestations of Cryptococcosis |
|
Definition
- Meningitis --> Most common presentation, usually insidious (gradual onset) with increased protein and decreased glucose in CSF. WBCs in CSF are primarily lymphocytes and cryptococcal antigen is positive
- Pneumonia and skin infections possible too
- Most commonly seen in HIV patients |
|
|
Term
|
Definition
- Caused by Aspergillus fumigatus, flavius and niger
- Mold infection that produces hyphae in tissue
- Aspergillus is ubiquitous in the environment
- Presentation: Allergic, aspergilloma and invasive forms
- Treatment: Voriconazole |
|
|
Term
Clinical Manifestation of Aspergillosis |
|
Definition
1. Allergic bronchopulmonary aspergillosis: Disease due to allergic response --> Becomes chronic
2. Aspergilloma: In post-tuberculosis, emphysema, or sarcoidosis patients --> Generally asymptomatic but can invade blood vessels and cause bleeding
3. Invasive aspergillosis: In profound neutropenics or graft-vs-host disease patients --> Hemorrhagic infarct in lung, brain, or hard palate due to hyphae invading blood vessels |
|
|
Term
|
Definition
- Caused by a variety of aseptate fungi
- Ubiquitous in environment
- Risk factors: Diabetic ketoacidosis and neutrophenia
- Thrives in diabetic ketoacidosis due to low pH and high glucose in blood
- Rhinocerebral mucormycosis: Rapidly progressive disease with black necrotic skin lesions
- Another angioinvasive fungus requiring severe debridement of tissue
- Treatment: Amphotericin B |
|
|
Term
|
Definition
- Causative agent: Pneumocystis jiroveci --> Doesn't have ergosterol in cell membrane so originally thought to be parasite
- Unknown reservoir in nature
- Risk factors: CD4 T-cells below 200
- Presentation: Pneumonia (PCP) with insidious presentation, non-productive cough, fever, and diffuse lung infiltrates |
|
|
Term
Diagnosis and Treatment of Pneumocystis |
|
Definition
- Diagnosis: Cannot be cultured so based on staining of sputum or other sample --> B-D-glucan testing
- Treatment: Anti-fungals don't work so trimethaprim/sulfamethoxazole (Bactrim) used |
|
|
Term
Thermally Dimorphic Fungi |
|
Definition
- Mold in nature but yeast or spherules in humans
- Histoplasmosis
- Coccidioidomycosis
- Blastomycosis
- Paracoccidiodomycosis
- Sporotrichosis
- Penicillosis marneffei |
|
|
Term
|
Definition
- Agent: Histoplasma capsulatum
- Obligate intracellular pathogen that replicates by budding
- Prominent in the Ohio and Mississippi River Valleys, Caribbean, and Central America
- Presentation: Acute pulmonary disease that is usually asymptomatic --> Can progress to pericarditis, hilar and mediastinal lymphadenopathy
- Outcomes: Complete recovery with or without latency, chronic pulmonary histoplasmosis, and progressive dissemination histoplasmosis |
|
|
Term
Manifestation, Diagnosis, and Treatment of Histoplasmosis |
|
Definition
- Manifestation: Progressive SOB, weight loss, fever, low pO2 sat, diffuse crackles in both lungs --> Looks alot like PCP
- Diagnosis: Histopathology, serology or antigen test
- Treatment: Amphotericin B and HIV testing |
|
|
Term
|
Definition
- Agents: Coccidioides imminitis and posadasii
- Dimorphic: Spherules with endospores in human
- Prevalence: Southwestern US and Latin America
- Affects apparently immunocompetent but more common in immunocompromised |
|
|
Term
Clinical Manifestation of Coccidioidomycosis |
|
Definition
- Most (~60%) are asymptomatic
- Incubation: 1-3 weeks
- Symptoms: Cough, fever, chills, weakness, and arthralgias (~40%)
- Erythema nodosum and erythema multiforme --> Painful skin lesions
- Residual pulmonary nodule/cavity (~5%)
- Progressive lung infections or disseminated disease (<1%) --> Coccidioidal meningitis |
|
|
Term
Diagnosis and Treatment of Coccidioidomycosis |
|
Definition
- Diagnosis: Culture, histopathology, or serology (not helpful in AIDS patients, antibodies don't develop)
- Treatment: Fluconazole |
|
|
Term
|
Definition
- Agent: Blastomyces dermatitidis
- Large, broad-based yeast buds in human
- Prevalance: SE and South central US states, Great Lakes and St. Lawrence River Valley
- Presentation: Lung, skin and bone infections
- Affects immunocompetent patients!! |
|
|
Term
|
Definition
- Agent: Paracoccidioides brasiliensis
- Yeast has multiple buds --> Pilot wheel
- Prevalence: South America particularly Brazil and Columbia
- Presentation: Lung, oral mucosa (granulomatous) and skin infections
|
|
|
Term
|
Definition
- Agent: Sporothrix schenckii
- Dimorphic fungi
- Cigar-shaped yeast in humans
- Found worldwide in association with soil and plants (roses and sphagnum moss)
- Presentation: Cutaneous disease that spreads through lymphatics --> Extracutaneous disease is rare!! |
|
|
Term
|
Definition
- Agent: Penicillium marneffei --> Reproduces by binary fission
- Dimorphic fungus: Yeast in humans
- Prevalence: SE Asia (endemic)
- Risk factors: AIDS patients
- Clinical manifestations: Often asymptomatic acute pulmonary disease (similar to histoplasmosis)
- Also presents with skin lesions that look like cryptococcus |
|
|
Term
Health Care Associated Infections |
|
Definition
- Infections obtained in individuals who have been hospitalized in the last 30 days or have been exposed to individuals who have been hospitalized in the last 30 days
- Usually due to opportunistic infections of normal flora colonizers
- Usually obtained from invasive devices (IVs or foleys)
- Endemic rates: Constant low rate of disease
- Epidemic rates: Increased rates |
|
|
Term
|
Definition
- ~40% of HAIs
- Catheters are used in 10-20% of patients but account for 70-90% of UTI cases
- Risk Factors: Age, skin integrity, degree of debilitation, and duration of catheterization
- Complications: Prostatitis, pyelonephritis or bacteremia
- Common Agents: G- bacilli --> E. coli, Klebsiella spp, Proteus spp., Pseudomonas spp., Enterococcus and Candida albicans |
|
|
Term
|
Definition
- ~38% of HAIs
- Develop in 2-5% of surgical patients
- Usually acquired at the time of surgery due to direct inoculation of flora
- Pre-operative antibiotic prophylaxis is a risk factor |
|
|
Term
Hospital Acquired Respiratory Tract Infections |
|
Definition
- 10-15% of HAIs --> Highest mortality (50-80%)
- Highest risk in the ICU due to intubation
- Pathogenesis: Aspiration during sleep or by inhalation of infectious aerosols (less common)
- Agents: Normal flora --> Changes once pt enters the hospital and becomes more colonized by resistant organisms
- Risk Factors: Mechanical ventilation, age >70, chronic lung disease, chest surgery, depressed consciousness, large volume aspiration, and antacid treatment/H2 blocker |
|
|
Term
Hospital Acquired Bloodstream Infections |
|
Definition
- 5% of HAIs
- Due to IV catheter use!!
- Phelbitis, cellulitis, and bacteremia possible
- Risk Factors: Age, underlying disease, burns, type of catheter, insertion site, and duration of use
- Agents: S. epidermidis, S. aureus, G- bacilli, Enterococcus, Candida albicans, etc |
|
|
Term
Other Hospitally Acquired Infections |
|
Definition
- Diarrhea --> Rotavirus, norovirus and C. diff
- Epidemic keratoconjunctivitis --> Adenovirus, pink eye
- Hepatitis A,B,&C
- HIV
- Tuberculosis --> ~50% of TB in Boston is treated at BMC |
|
|